Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

J. Douglas D. Rizzo MD, MS
Director, Center Associate Director, Professor
Department of Medicine
Division of Hematology and Oncology - Medicine
Senior Scientific Director
Center for International Blood and Marrow Transplant Research (CIBMTR)
And
Associate Director of Clinical Operations
Froedtert & the Medical College of Wisconsin Cancer Center
Cancer Service Line Director
And
Professor of Medicine
Blood and Marrow Transplantation Program
Medical College of Wisconsin

OFFICE ADDRESS:
Clinical Cancer Center
9200 W Wisconsin Ave
Milwaukee, WI 53226
Phone: 414-805-0678
Fax: 414-805-0714
Email: drizzo@mcw.edu

EDUCATION:
09/1982 - 06/1986 B.S., Virginia Polytechnic Institute and State University, Blacksburg, VA
09/1986 - 09/1990 M.D., Johns Hopkins University School of Medicine, Baltimore, MD
05/2005 M.S. Epidemiology, Medical College of Wisconsin, Milwaukee, WI

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
07/1990 - 06/1993 Resident, Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
07/1994 - 06/1998 Senior Clinical Fellow, Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD
07/1995 - 06/1998 Senior Clinical Fellow, Department of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD
07/1996 - 06/1998 Robert Wood Johnson Clinical Scholars Program, Johns Hopkins University School of Medicine, Baltimore, MD

FACULTY APPOINTMENTS:
07/1991 - 06/1993 Assistant Instructor, Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
07/1993 - 06/1994 Staff Internist, Internal Medicine Practice, Wilkens Avenue MedicalCenter, IPA, Baltimore, MD
09/1993 - 06/1996 Secondary Clinical Staff, Emergency Medicine, Johns Hopkins Bayview Medical Center, Baltimore, MD
07/1998 - 05/2003 Assistant Scientific Director, International Bone Marrow Transplant Registsry, Autologous Blood and Marrow Transplant Registry, Medical College of Wisconsin, Milwaukee, WI
07/1998 - 05/2003 Assistant Professor of Medicine, Division of Neoplastic Diseases, Medical College of Wisconsin, Milwaukee, WI
06/2003 - 06/2008 Associate Professor of Medicine, Department of Medicine, Division of Neoplastic Diseases and Related Disorders, Medical College of Wisconsin, Milwaukee, WI
06/2003 - 12/2013 Associate Scientific Director, Department of Medicine, CIBMTR, Medical College of Wisconsin, Milwaukee, WI
07/2005 - 10/2006 Acting Clinical Director, Inpatient Hematopoietic Cell Transplant Program, Medical College of Wisconsin, Milwaukee, WI
07/2008 - Present Professor of Medicine, Department of Medicine, Division of Hematology and Oncology (with Tenure), Medical College of Wisconsin, Milwaukee, WI
11/2012 - Present Associate Director of Clinical Operations for Froedtert & the Medical College of Wisconsin Cancer Center; Cancer Service Line Director, Froedtert & the Medical College of Wisconsin, 9200 West Wisconsin Avenue, Suite C5500, Milwaukee, WI 53226
01/2014 - Present Senior Scientific Director, Department of Medicine, CIBMTR, Medical College of Wisconsin, Milwaukee, WI

EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
1995 - 1996 Coordinator, Oncology Center Journal Club Instructor, Medical Student Clinical Skills Course Johns Hopkins University School of Medicine, Baltimore, MD
2002 - Present Member, Fellowship Committee, Medical College of Wisconsin, WI, Division of Hematology and Oncology, Milwaukee, WI
2010 - 2013 Member Representative for the Faculty Council, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

HOSPITAL STAFF PRIVILEGES:
07/1993 - 06/1994 St. Agnes Hospital, Baltimore, MD
09/1993 - 10/1996 Johns Hopkins Bayview Medical Center, Baltimore, MD
07/1998 - Present Froedtert Memorial Lutheran Hospital, 9200 W. Wisconsin Avenue, Milwaukee, WI

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
American Board of Internal Medicine
09/1993
09/2003
ABIM - Medical Oncology
11/1998
11/2008
ABIM - Hematology
11/1999
11/2009
ABIM - Medical Oncology - Maintenance of certification
02/2012
12/2022
 
Licensure
Number Issue DateExpiration
Pennsylvania Internal Medicine (Inactive)
MD-047878-L
1992
None
Maryland Internal Medicine (Inactive)
D44529
1993
None
Wisconsin Internal Medicine (Active)
39926
1998
None
 

AWARDS AND HONORS:
04/1986 Virginia Tech Man of the Year, Outstanding Student in the College of Arts and Sciences
04/1996 Virginia Tech Outstanding Young Alumnus

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
1993 - Present American College of Physicians
1996 - Present American Society of Hematology
1997 - Present American Society of Clinical Oncology
2002 - Present American Society for Blood and Marrow Transplantation

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorship
2003 - 03/2005 Contributing Editor, ASH News
Journal Review
Scientific Reviewer, Biology Blood and Marrow Transplantation
Scientific Reviewer, Journal of Clinical Oncology
Scientific Reviewer, Bone Marrow Transplantation
Scientific Reviewer, Blood

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
12/1997 - 11/2000 Member, Committee on Optimization of Hematologic Care, American Society of Hematology
12/2000 - 11/2002 Chair, Committee on Optimization of Hematologic Care, American Society of Hematology
10/2001 - 10/2004 Member, American Society of Hematology Clinical Research Training Institute Task Force
12/2001 - 12/2005 Consultant, Data Safety Monitoring Board, Antigenics, Inc. A multi-center, randomized phase III study of adjuvant Oncophage versus observation in patients with high-risk of recurrence after surgical treatment of renal cell carcinoma
06/2002 - 02/2012 Member, Evidence-Based Review Steering Committee, American Society for Blood and Marrow Transplantation
10/2002 - 05/2003 Member, Task Force on Quality Care and Clinical Issues, American Society of Hematology
12/2002 Invitee, Task Force to Determine Optimal Clinical Trials to Evaluate Erythropoietins, Clinical Investigations Branch, National Cancer Institute
12/2002 - 12/2006 Member, Committee on Government Affairs, American Society of Hematology
02/2003 - 06/2005 Invited Faculty/Mentor, Clinical Research Training Institute, American Society of Hematology
04/2003 - 12/2004 Reviewer, ASH Clinical Scholar Award Study Section, American Society of Hematology
2003 - 2005 Expert Advisor, Technical Expert Panel, Blue Cross Blue Shield Association
06/2004 - 06/2005 Invited Member, NIH Chronic GVHD Consensus Development Project, National Institutes of Health
10/2004 - 11/2007 Co-Chair, ASH/ASCO Erythropoietin stimulants guideline (II) panel, American Society of Hematology/American Society of Clinical Oncology
2005 Expert Advisor, Evidence-Based Practice Center Sytematic Review. “Effectiveness of Epoietin and Darbepoietin for Managing Anemia in Patients Undergoing Cancer Treatment”
01/2006 - Present Member, ASBMT Committee on Standardization of Outcomes Reporting and RFIs, American Society for Blood and Marrow Transplantation
04/2006 - Present Member, ASBMT Quality Outcomes Committee, American Society for Blood and Marrow Transplantation
08/2007 Invited Faculty/Mentor, Clinical Research Training Institute, American Society of Hematology
12/2007 - 12/2012 Member, ASH Subcommittee on Quality of Care, American Society of Hematology
03/2011 - 07/2016 Member, ASH and College of American Pathologists Acute Leukemia Workup Guideline Development Panel, American Society of Hematology
2011 - 2017 Physician Consultant, OptumHealth Bone Marrow/Stem Cell Transplant Expert Panel
2011 - 2012 Expert Panelist, Center Outcomes Reporting, Blue Cross Blue Shield
05/2012 - 06/2013 Member, ASH Quality Task Force, American Society of Hematology
06/2012 - 06/2014 Member, Medicare Evidence Development & Coverage Advisory Committee, MEDCAC
01/2014 - Present Member, FACT Clinical Outcomes Task Force
08/2015 - 07/2016 Member, NIH Blood and Marrow Transplant Late Effects Workgroup, NIH

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Stem Cell Therapeutic Outcomes Database (HHSH25020170006C)
Source:
U.S. Department of Health and Human Services Health Resources and Services Administration
Role:
Project Director (PI)
PI:
J. Douglas Rizzo, MD, MS
Dates:
09/27/2017 - 09/26/2022
Direct Funds:
$18,608,009
 
Title:
Identification of a Molecular Biomarker for Social Disparities in Cancer Outcomes (2 year award with third year provisional)
Source:
Clinical and Translational Science Institute Mentored Career Development (KL2) Award, supported by grant ULTR001436 and KL2TR001438 from the Clinical and Translational Science Award (CTSA) program of the NCATS
Role:
Primary Mentor
PI:
Jennifer M. Knight, MD, MS, FAPM
Direct Funds:
$255,000
 
Pending
Peer Review
Title:
Using HL7 FHIR to exchange Hematopoietic Cell Transplant and Cellular Therapy data to support cancer research
Source:
NIH/NCI
PI:
J. Douglas Rizzo, MD, MS
Dates:
07/01/2018 - 06/23/2023
Direct Funds:
$3,538,378
 
Prior
Peer Review
Title:
Breast Cancer Research
Source:
Medical College of Wisconsin
Role:
Principal Investigator
PI:
J. Douglas Rizzo, MD, MS
Dates:
01/01/1999 - 03/31/2001
Direct Funds:
$15,000
 
Title:
Long-Term Outcome of Blood and Marrow Transplantation (K23-CA-82350)
Source:
National Institutes of Health, National Cancer Institute
Role:
Principal Investigator
PI:
J. Douglas Rizzo, MD, MS
Dates:
09/03/1999 - 06/30/2004
Direct Funds:
$663,019
 
Title:
Assessment of Policies and Practices for Reducing Opportunistic Infections among BMT Recipients
Source:
Centers for Disease Control
Role:
Co-Principal Investigator
Dates:
09/07/1999 - 11/07/1999
Direct Funds:
$13,378
 
Title:
Zenepax as Primary Treatment for Acute Graft-Versus-Host Disease
Source:
Roche
Role:
Site Principal Investigator
Dates:
02/17/2000 - 09/01/2004
Direct Funds:
$79,464
 
Title:
Data Resource for Analyzing Blood and Marrow Transplants: Stem Cell Transplant Center Factors
Source:
Agency for Healthcare Research & Quality
Role:
Co-Investigator
Dates:
01/01/2002 - 12/31/2003
Direct Funds:
$66,667
 
Title:
Assessment of Health State Utilities in Hematopoietic Stem Cell Transplant Survivors
Source:
Lance Armstrong Foundation
Role:
Co-Investigator
Dates:
01/01/2004 - 12/31/2004
Direct Funds:
$21,455
 
Title:
A Public System for Electronic Exchange of Clinical Network Data: A Collaborative Effort of the International Bone Marrow Transplant Registry and the National Marrow Donor Foundation
Source:
National Institutes of Health/National Heart, Lung & Blood Institute (subcontract with the National Marrow Donor Program)
Role:
Co-Investigator
Dates:
09/30/2004 - 09/29/2007
Direct Funds:
$315,463
 
Title:
Stem Cell Therapeutic Outcomes Database (HHSH234200637015C)
Source:
U.S. Department of Health and Human Services Health Resources and Services Administration
Role:
Project Director (PI)
PI:
J. Douglas Rizzo, MD, MS
Dates:
09/27/2006 - 09/26/2012
Direct Funds:
$16,982,549
 
Title:
A Data Resource for Analyzing Blood and Marrow Transplants (U24 CA76518)
Source:
National Institutes of Health/National Cancer Institute
Role:
Co-Investigator
PI:
Mary M. Horowitz, MD, MS
Dates:
03/01/2008 - 02/28/2013
Direct Funds:
$12,881,026
 
Title:
RDSafe: A Multiinstitutional Study of HSC Donor Safety and Quality of Life (1R01-HL085707-01A1)
Source:
National Institutes of Health/National Heart, Lung & Blood Institute (subcontract with University of Utah School of Medicine)
Role:
Co-Principal Investigator
PI:
Michael Pulsipher, MD
Dates:
12/01/2008 - 11/30/2013
Direct Funds:
$117,308
 
Title:
Stem Cell Therapeutic Outcomes Database (HHSH250201200016C)
Source:
U.S. Department of Health and Human Services Health Resources and Services Administration
Role:
Project Director (PI)
PI:
J. Douglas Rizzo, MD, MS
Dates:
09/27/2012 - 09/26/2017
Direct Funds:
$16,576,695
 
Title:
Pilot study using propranolol to decrease gene expression of stress-mediated beta-adrenergic pathways in hematopoietic stem cell transplant recipients
Source:
Leidos Biomed/NCI Network on Biobehavioral Pathways in Cancer; NCI Contract No. HHSN261200800001E
Role:
Co-Investigator
PI:
Jennifer M. Knight, MD, MS, FAPM
Dates:
03/23/2015 - 09/30/2016
Direct Funds:
$48,916
 

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
Rizzo JD, Stem Cell Transplant Basics, IBMTR Data Management Workshop, Milwaukee, WI, 11/1998
Rizzo JD, Basics of BMT, IBMTR Data Management Workshop, Milwaukee, WI, 10/1999
Rizzo JD, Diagnosis and Management of Hypereosinophilia Syndrome, Department of Medicine Grand Rounds, Medical College of Wisconsin, 03/2000
Rizzo JD, Conditioning Regimens for Transplantation, IBMTR Data Management Workshop, Milwaukee, WI, 09/2000
Rizzo JD, Introduction to BMT, IBMTR Data Management Workshop, Milwaukee, WI, 09/2001
Rizzo JD, Lymphoma Overview, IBMTR Data Management Workshop, Milwaukee, WI, 09/2001
Rizzo JD, Follow-up Begins Pre-Transplant, IBMTR Data Management Workshop, Milwaukee, WI, 09/2002
Rizzo JD, Early and Late Complications of HSCT, Hematology/Oncology Fellowship Lecture Series, Milwaukee, WI, 10/2002
Rizzo JD, Early and Late Complications of HSCT, Hematology/Oncology Fellowship Lecture Series, Milwaukee, WI, 10/2003
Rizzo JD, ESAs in Patients with Cancer, Department of Medicine, Grand Rounds, Milwaukee, WI, 05/2009
Rizzo, JD, CIBMTR Update, Invited oral presentation for the 2012 Fall Clinical Research Professional's Data Management (CRP/DM) Conference, Milwaukee, WI, 10/2012
Local and national lectures for HCT clinical research associate conferences averaging more than 5 lectures annually not listed beyond 2003 for brevity
 
National
Rizzo JD, Tunis S, Bass EB, Technology Assessment for Genetic Testing for BRCA-1 and BRCA-2, Technology Assessment Committee of Blue Cross Blue Shield of Maryland, Baltimore, Maryland, 05/1997
Rizzo JD, Vogelsang GB, Outcomes Measures in Hematologic Malignancies, Johns Hopkins Fifth Annual Progress in Hematologic Malignancies and Bone Marrow Transplantation, Baltimore, Maryland, 09/1997
Rizzo JD, Second cancers workshop, Tandem BMT Meetings, Keystone, Colorado, 02/1999
Rizzo JD, Second cancers after transplantation, Roundtable, Tandem BMT Meetings, Anaheim, California, 03/2000
Rizzo JD and Lichtin AE (Moderators), Health Services and Outcomes Research Simultaneous sessions, American Society of Hematology, Orlando, Florida, 12/2001
Rizzo JD (Chair), Bennett C, Seidenfeld J, Lichtin AE, Red Cells III: Erythropoietin: a paradigm for the development of practice guidelines, American Society of Hematology, Orlando, Florida, 12/2001
Rizzo JD, Late sequelae of BMT: new neoplastic complications. International Concurrent session, Tandem BMT Meetings, Orlando, Florida, 02/2002
Rizzo JD, Follow-up begins pretransplant, Clinical Research Associates Data Management Conference, Tandem BMT Meetings, Keystone, CO, 01/2003
Rizzo JD, Chair, Transplant center resources, Concurrent Scientific Sessions, Tandem BMT Meetings, Keystone, CO, 02/2003
Rizzo JD, Red tired, Oral Abstract Discussant, 39th Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, 06/2003
Rizzo JD, How do age and weight affect outcome after stem cell transplantation?, Oral Abstract Discussant, 39th Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, 06/2003
Rizzo JD, Medical Record Interpretation, Tandem BMT Meetings, Orlando, FL, 02/2004
Rizzo JD, New malignancies after hematopoietic stem cell transplantation, Tandem BMT Meetings, Orlando, FL, 02/2004
Rizzo JD: Socie G, Workshop to develop Recommendations for Post-transplant Screening and Prevention, Tandem BMT Meetings, Orlando, FL, 02/2004
Rizzo JD, Post HSCT/DCI-Disease response over time, Clinical Research Professionals Data Management Conference, Minneapolis, MN, 11/2005
Rizzo JD, CIBMTR and Patient Advocacy, HRSA Patient Advocacy Conference, invited participant, Rockville, MD, 11/2005
Rizzo JD, Requirements for the Stem Cell Therapeutics Outcomes Database. Oral presentation during Concurrent Scientific Session, Tandem BMT Meetings, Keystone, CO, 02/2007
Rizzo JD, What are the new requirements for the SCTOD?, Invited oral presentation for ASBMT Medical Directors Conference, Keystone, CO, 02/2007
Rizzo JD, What are the data requirements for the SCTOD?, Invited oral presentation for BMT Center Administrators Conference, Keystone, CO, 02/2007
Rizzo JD, Late Effects Post Transplant: Recommended screening and preventive practices, Invited oral presentation for BMT Pharmacists Conference, Keystone, CO, 02/2007
Rizzo JD, Invited participant, National Heart, Lung and Blood Institute’s Technology and Data Standards Initiative Workshop, Bethesda, MD, 05/2007
Rizzo JD, Invited Participant, Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium, Ann Arbor, MI, 06/2007
Rizzo JD, Silver S, Briefing on the use of ESAs for Cancer Patients, Invited speaker, Presentation to the House Ways and Means Committee/Congressional Health staffers, Rayburn Office Building, Washington DC, 10/23/2007
Rizzo JD, Jones R, Conference developer, planners and co-facilitators for 150 data and IT personnel regarding new initiatives for collecting and reporting data to the SCTOD, ASBMT/CIBMTR/NMDP Information Technology Summit, Minneapolis, MN, 01/18/2008 - 01/19/2008
Rizzo JD, SCTOD update: Where are we now, and where are we headed?, ASBMT Medical Directors Conference, San Diego, CA, 02/2008
Rizzo JD, Chair, Education Session: Erythropoiesis-Stimulating Agents in Cancer Chemotherapy: Recent Developments and Clinical Implications. “ESAs, What do we really know”, Invited speaker, American Society of Clinical Oncology Annual Meeting, Chicago, IL, 05/30/2008
Rizzo JD, Conference developer, planner and chair, Center Specific Outcomes in HCT Forum, Milwaukee, WI, 09/2008
Rizzo JD, LeMaistre CF, Jones RB, Center-Specific Outcomes Analysis and Reporting – What is Next?, Invited oral presentation for BMT Medical Directors Conference, Tampa, FL, 02/2009
Rizzo JD, Jones RB, SCTOD Update, Invited oral presentation for BMT Center Administrators Conference, Tampa, FL, 02/2009
Rizzo JD, SCTOD/AGNIS Update, Invited oral presentation for Clinical Research Professionals Data Management Conference, Tampa, FL, 02/2009
Rizzo JD, Optimizing CIBMTR Data Reporting, Invited oral presentation at the Annual International Umbilical Cord Blood Transplantation Symposium, Manhattan Beach, CA, 06/2009
Rizzo JD, Jones RB, SCTOD Update, Invited oral presentation for BMT Center Administrators Conference, Orlando, FL, 02/2010
Rizzo JD, Update on Coverage with Evidence Development for Medicare MDS Patients, Invited oral presentation for BMT Medical Directors Conference, Honolulu, HI, 02/2011
Rizzo JD, Jones RB, SCTOD Update, Invited oral presentation for BMT Center Administrators Conference, Honolulu, HI, 02/2011
Rizzo JD, Post Transplant Survivorship Issues, Invited oral presentation for Transplant Medicine in Blood Cancers Conference, Madison, WI, 04/2011
Rizzo JD, Bone Marrow Transplantation and MDS, Coverage with Evidence, Invited oral presentation for ASH/ASCO Carrier Advisory Committee Network Meeting, Alexandria, VA, 07/2011
Rizzo JD, What Can We Learn From Other Experiences?, Invited oral presentation for Consensus Conference on Transplant Program Quality and Surveillance, Sponsored by the Scientific Registry of Transplant Recipients, Arlington, VA, 02/2012
Rizzo JD, SCTOD Update, Invited oral presentation for BMT Center Administrators Conference, BMT Tandem Meetings, San Diego, CA, 02/2012
Rizzo JD, Update: 2011 Late Effects Monitoring Recommendations, Invited oral presentation for BMT Conference, BMT Tandem meetings, San Diego, CA, 02/2012
Rizzo, JD, Survivorship for the Recipient of HCT for Multiple Myeloma, Invited oral presentation for the 10th Annual Multiple Myeloma Conference, Sponsored by the Leukemia & Lymphoma Society, Sheboygan, WI, 09/2012
Rizzo, JD, Secrets of a Great Talk: How to Create and Deliver Effective Presentations, Invited oral presentation for the Trade Secrets of a Successful Academic Session for the 54th American Society of Hematology Annual Meeting and Exposition, Atlanta, GA, 12/2012
Rizzo, JD, CIBMTR Update: Clinical Research Professionals/Data Management Conference, Invited oral presentation for the BMT Tandem Meetings, Salt Lake City, UT, 02/2013
Rizzo, JD, How Programs and Health Plans are Using Data to Improve Program Performance and Beyond Electronic Data Capture to Data Sharing, Invited oral presentation for the BMT Center Administrators Conference, BMT Tandem Meetings, Salt Lake City, UT, 02/2013
Rizzo, JD, Quality, Transparency, and Patient Safety in BMT, Invited oral presentation for the Blood and Marrow Stem Cell Transplant: A Forum on Quality, Transparency, Cost & Value, Chicago, IL, 07/2013
Rizzo, JD, Data from CIBMTR: How You Can Use It., Invited oral presentation for BMT Tandem Meetings, Dallas, TX, 02/2014
Rizzo, JD, How Can We Overcome the Current Barriers to Transplantation? ASBMT President's Conference, Invited oral presentation for BMT Tandem Meetings, Dallas, TX, 03/2014
Rizzo, JD, CIBMTR Data Highlights, Center Volumes and Center Outcomes Reporting in HCT, Invited oral presentation for the Clinical Research Professional/Data Management Conference, BMT Tandem meetings, San Diego, CA, 02/2015
Rizzo, JD, Center Outcomes Reporting in HCT: Recommendations from the Center Outcome Forum 2014, Invited oral presentation for the BMT Center Administrators Conference, BMT Tandem meetings, San Diego, CA, 02/2015
Rizzo, JD, Quality Measurement in HCT, Invited oral presentation for the Aligning Quality and Value in HCT meeting, Minneapolis, MN, 07/15/2015
Rizzo, JD, Transplant Center Specific Outcomes Analysis - Generation and Use, Invited oral presentation for the NMDP Council Meeting 2015, Minneapolis, MN, 11/06/2015
Rizzo, JD, Center Specific Survival Analysis Methods, Invited oral presentation for the BMT Center Administrators Conference, BMT Tandem meetings, Honolulu, HI, 02/2016
Rizzo, JD, Center Specific Outcomes Reporting: How can CIBMTR help centers' performance improvement efforts?, Annual Sarah Cannon Blood Cancer Network meeting, Denver, Colorado, 09/12/2016
Rizzo, JD, Update on CIBMTR's response to CMS' Coverage with Evidence Development (CED) for Blood Stem Cell Transplantation Indications, Invited lecture for the HHS Advisory Council on Blood Stem Cell Transplantation (ACBSCT), Arlington, Virginia, 09/13/2016
Rizzo, JD, Measuring Quality of Life, Implementing Quality & Value in HCT, Minneapolis, Minnesota, 10/19/2016 - 10/20/2016
Rizzo, JD, Vaule-Based Purchasing and Access, Implementing Quality & Value in HCT, Minneapolis, Minnesota, 10/19/2016 - 10/20/2016
Rizzo, JD, Quality Improvement in HCT, Implementing Quality & Value in HCT, Minneapolis, Minnesota, 10/19/2016 - 10/20/2016
Rizzo, JD, CIBMTR Data Life Cycle, Invited oral presentation for BMT Tandem Meetings, Kissimmee, Florida, 02/21/2017
Rizzo, JD, CIBMTR Update, Invited oral presentation for BMT Center Administrative Director SIG Meeting, BMT Tandem Meeting, Kissimmee, Florida, 02/23/2017
Rizzo, JD, CIBMTR Data Life Cycle, Invited oral presentation for BMT Tandem Meetings, Clinical Research Professionals Session, Salt lake City, UT, 02/20/2018
Rizzo, JD, CIBMTR Center Specific Analysis Update, Invited oral presentation for BMT Center Administrative Director SIG Meeting, BMT Tandem Meeting, Salt lake City, UT, 02/22/2018
Rizzo, JD, See It to Believe It: CIBMTR Enhanced Data Back to Center (eDBtC) and Center Performance Applications to Visualize Program Data, Invited oral presentation for BMT Tandem Meetings, Salt lake City, UT, 02/23/2018
 
International
Sluiters JF, Schalekamp L, Dirks I, Rizzo JD, Cryptosporidium parvum antibodies in normal healthy blood donors, VIth European Multicolloquium of Parasitology, The Hague, Netherlands, 1992
Rizzo JD, Center specific outcome reporting for HCT in the United States, Swiss Blood Stem Cells JACIE Conference, Berne, Switzerland, 11/2009
Rizzo JD, Current Indications for HCT, Workshop of the Worldwide network for Blood and Marrow Transplantation (WBMT) in collaboration with the WHO, Hanoi, Vietnam, 11/2011
Rizzo JD, Screening and prevention of Late Effects., EBMT Late Effects Working Party Education Day, Barcelona, Spain, 11/2011
Rizzo JD (Session Chair/Moderator), Establishing a Transplant Program., Workshop of the Worldwide network for Blood and Marrow Transplantation (WBMT) in collaboration with the WHO., Hanoi, Vietnam, 11/2011
Rizzo, JD, Benefits and Challenges of the Stem Cell Act on HCT in the United States, Invited lecture for the Japanese Office of the Ministry of Health, Labor and Welfare, Tokyo, Japan, 01/2013
Rizzo JD, Implications of the Stem Cell Act and the Stem Cell Therapeutic Outcomes Database on HCT in the United States, Invited lecture to the Japanese Society for HCT, Tokyo, Japan, 01/2013
Rizzo JD, Value of Outcomes Registries in HCT, Invited lecture for the EMBMT Data Management Workshop for Hematopoietic Stem Cell Transplantation (HSCT) Centers, Tunis, Tunisia, 11/2014
Rizzo JD, Clinical Outcome Reporting: The US experience of the Stem Cell Therapeutic Outcomes Database (SCTOD)., Invited lecture for the EBMT 41st Annual Meeting of the European Society of Blood and Marrow Transplantation,, Istanbul, Turkey, 03/2015
Rizzo, JD, Care From a Distance, Invited lecture for the CBMTG 2016 Annual Conference, Vancouver, British Columbia, Canada, 04/26/2016
Rizzo, JD, Data and Center Specific Survival Analysis CIBMTR, Invited lecture for the 20th Congress of the Brazilian Society of Bone Marrow Transplantation, Fortaleza, Ceara, Brazil, 08/24/2016 - 08/27/2016
Rizzo, JD, Quality of life, support and late effects in Bone Marrow Transplants, 20th Congress of the Brazilian Society of Bone Marrow Transplantation, Fortaleza, Ceara, Brazil, 08/24/2016 - 08/27/2016
 

COMMITTEE SERVICE:
Medical College
2000 - 2003 Health Policy Institute Representative, Faculty Council, Medical College of Wisconsin
2003 - 2004 Faculty Benefits Committee,, Faculty Council, Medical College of Wisconsin
2010 Member, MCW Tissue Bank Executive Committee, Medical College of Wisconsin
2010 - 2011 Appointed Member, Research Data Security Task Force, Medical College of Wisconsin
2010 - 2013 Member, Representative for the Faculty Council, Medicine, Medical College of Wisconsin
2011 - 2012 Appointed Member, President and Dean's IT Advisory Committee, Medical College of Wisconsin
2011 - 2013 Appointed Physician Champion, EPIC Oncology Solutions Implementation, Hematology/Oncology, Medical College of Wisconsin
2012 - Present Member, Joint Strategic Planning Committee, Froedtert and the Medical College of Wisconsin
2012 - Present Member, Medical College Physicians Workforce Planning Committee, Medical College of Wisconsin
2013 Member, Service Line Planning Committee, Froedtert and the Medical College of Wisconsin
2013 Member, Chief Medical Officer-Enterprise Search Committee, Froedtert and the Medical College of Wisconsin
2015 Member, Medical College of Wisconsin Chair of Radiation Oncology Search Committee, Medical College of Wisconsin
 

MEDICAL COLLEGE TEACHING ACTIVITIES:
Resident and Fellow Education
10/2002 Post-transplant toxicities, Fellow Education Lecture
01/2003 Basics of BMT, Resident Education Lecture
07/2003 BMT for the Internist, Resident Education Lecture
02/2004 Post-transplant toxicities, Fellow Education Lecture
07/2004 BMT for the Internist, Resident Education Lecture
01/2005 Overview of BMT, Fellow Education Lecture - annually
 

MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED:
Medical Students
Derek Serna, Medical College of Wisconsin, 05/2001 - 05/2005 M.D. Candidate
Michael Rosenblum, M.S., Medical College of Wisconsin, 01/2002 - 05/2004 M.D., Ph.D. Candidate
Nan Wu, Medical College of Wisconsin, 2007 Summer Research Trainee
 
Graduate Students
PhD Committees
Jing Tao Wu, Medical College of Wisconsin, 07/1999 - 05/2001 Biostatistics Ph.D.
Thomas Joshua, Medical College of Wisconsin, 01/2005 - 12/2006
Melissa B. Warden, Medical College of Wisconsin, 09/2005 - 05/2007
 
Faculty
Fausto Loberiza, M.D., M.S., Medical College of Wisconsin, 01/2001 - 12/2004
Tasleem Raza, M.D., Medical College of Wisconsin, 01/2002 - 05/2005
Parameswaran Hari, M.D., Medical College of Wisconsin, 05/2005 - 05/2006
Tim Fenske, M.D., Medical College of Wisconsin, 07/2005 - 06/2008
Jennifer Knight, M.D., Medical College of Wisconsin, 07/2011 - Present MCW Clinical Research Scholars Program
Maheen Abidi, M. D., Medical College of Wisconsin, 01/2014 - 06/2016 Infectious Diseases (mentoring committee)
 

PROGRAMMATIC DEVELOPMENTS:
Educational Programs
Faculty
2003 - 2004 MCW Faculty Leadership Development Program, collaboration of MCW with University of Wisconsin Milwaukee Business Administration Program. Intensive leadership development course
10/11/2015 - 10/23/2015 Leadership Development for Physicians in Academic Health Centers, Harvard T.H. Chan School of Public Health
 
 
 
 

ABSTRACT REVIEWER AND PROGRAM COMMITTEE:
2002 American Society of Hematology Annual Meeting, Health Services Research Category
2005 American Society of Hematology Annual Meeting, Clinical Care-Recurrence, Secondary Neoplasia, and Late Complications after Transplantation
2007 American Society of Hematology Annual Meeting, Session Moderator, Autologous Transplantation for Myeloma
2008 American Society of Clinical Oncology Annual Meeting, Education Session Chair, Update on the use of Erythroid Stimulants


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Rizzo JD, Rowe SA. Meningism in a ten-month-old infant during OKT3 therapy. J Heart Transplant. 1990 Nov-Dec;9(6):727-8.
2. SundarRaj N, Rizzo JD, Anderson SC, Gesiotto JP. Expression of vimentin by rabbit corneal epithelial cells during wound repair. Cell Tissue Res. 1992 Feb;267(2):347-56.
3. Rizzo JD, Strom BL, Berlin J. Replacement of central vascular catheters. N Engl J Med. 1993 Feb 11;328(6):445-6.
4. Rizzo JD, Powe NR. Methodological hurdles in conducting pharmacoeconomic analyses. Pharmacoeconomics. 1999 Apr;15(4):339-55.
5. Rizzo JD, Vogelsang GB, Krumm S, Frink B, Mock V, Bass EB. Outpatient-based bone marrow transplantation for hematologic malignancies: cost saving or cost shifting? J Clin Oncol. 1999 Sep;17(9):2811-8.
6. Rizzo JD, Seidenfeld J, Piper M, Aronson N, Lichtin A, Littlewood TJ. Erythropoietin: a paradigm for the development of practice guidelines. Hematology Am Soc Hematol Educ Program. 2001:10-30.
7. Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. Biol Blood Marrow Transplant. 2001;7(11):620-30.
8. Lazarus HM, Loberiza FR Jr, Zhang MJ, Armitage JO, Ballen KK, Bashey A, Bolwell BJ, Burns LJ, Freytes CO, Gale RP, Gibson J, Herzig RH, LeMaistre CF, Marks D, Mason J, Miller AM, Milone GA, Pavlovsky S, Reece DE, Rizzo JD, van Besien K, Vose JM, Horowitz MM. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). Bone Marrow Transplant. 2001 Feb;27(4):387-96.
9. Anderlini P, Rizzo JD, Nugent ML, Schmitz N, Champlin RE, Horowitz MM, IBMTR Statistical Center of the International Bone Marrow Transplant Registry, Medical College of Wisconcin, Milwaukee, WI, USA, EBMT, Kiel, Germany. Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases. Bone Marrow Transplant. 2001 Apr;27(7):689-92.
10. Horowitz MM, Loberiza FR, Bredeson CN, Rizzo JD, Nugent ML. Transplant registries: guiding clinical decisions and improving outcomes. Oncology (Williston Park). 2001 May;15(5):649-59; discussion 663-4, 666.
11. Klein JP, Rizzo JD, Zhang MJ, Keiding N. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis. Bone Marrow Transplant. 2001 Nov;28(10):909-15.
12. Klein JP, Rizzo JD, Zhang MJ, Keiding N. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling. Bone Marrow Transplant. 2001 Dec;28(11):1001-11.
13. Rizzo JD, Elias AD, Stiff PJ, Lazarus HM, Zhang MJ, Oblon DJ, Pecora AL, Hale GA, Horowitz MM. Autologous stem cell transplantation for small cell lung cancer. Biol Blood Marrow Transplant. 2002;8(5):273-80.
14. Loberiza FR Jr, Rizzo JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC, Lee SJ. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol. 2002 Apr 15;20(8):2118-26.
15. Sierra J, Pérez WS, Rozman C, Carreras E, Klein JP, Rizzo JD, Davies SM, Lazarus HM, Bredeson CN, Marks DI, Canals C, Boogaerts MA, Goldman J, Champlin RE, Keating A, Weisdorf DJ, de Witte TM, Horowitz MM. Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia. Blood. 2002 Sep 15;100(6):1997-2004.
16. Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS, American Society of Clinical Oncology. American Society of Hematology. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol. 2002 Oct 01;20(19):4083-107.
17. Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS, American Society of Clinical Oncology, Americcan Society of Hematology. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. Blood. 2002 Oct 01;100(7):2303-20.
18. Loberiza FR Jr, Serna DS, Horowitz MM, Rizzo JD. Transplant center characteristics and clinical outcomes after hematopoietic stem cell transplantation: what do we know? Bone Marrow Transplant. 2003 Mar;31(6):417-21.
19. Vandenberghe E, Ruiz de Elvira C, Loberiza FR, Conde E, López-Guillermo A, Gisselbrecht C, Guilhot F, Vose JM, van Biesen K, Rizzo JD, Weisenburger DD, Isaacson P, Horowitz MM, Goldstone AH, Lazarus HM, Schmitz N. Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries. Br J Haematol. 2003 Mar;120(5):793-800.
20. Metayer C, Curtis RE, Vose J, Sobocinski KA, Horowitz MM, Bhatia S, Fay JW, Freytes CO, Goldstein SC, Herzig RH, Keating A, Miller CB, Nevill TJ, Pecora AL, Rizzo JD, Williams SF, Li CY, Travis LB, Weisdorf DJ. Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study. Blood. 2003 Mar 01;101(5):2015-23.
21. Rosenblum MD, Bredeson CN, Chang CC, Rizzo JD. Subcutaneous plasmacytomas with tropism to sites of previous trauma in a multiple myeloma patient treated with an autologous bone marrow transplant. Am J Hematol. 2003 Apr;72(4):274-7.
22. Levine JE, Harris RE, Loberiza FR Jr, Armitage JO, Vose JM, Van Besien K, Lazarus HM, Horowitz MM, Bashey A, Bolwell BJ, Burns LJ, Cairo MS, Champlin RE, Freytes CO, Gibson J, Goldstein SC, Laughlin MJ, Lister J, Marks DI, Maziarz RT, Miller AM, Milone GA, Pavlovsky S, Pecora AL, Rizzo JD, Schiller G, Schouten HC, Zhang MJ, Lymphoma Study Writing Committee, International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry. A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. Blood. 2003 Apr 01;101(7):2476-82.
23. Lee SJ, Loberiza FR, Rizzo JD, Soiffer RJ, Antin JH, Weeks JC. Optimistic expectations and survival after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2003 Jun;9(6):389-96.
24. Rizzo JD, Williams S, Wu JT, Pecora AL, Lazarus HM, Bolwell B, Fields KK, Gale RP, Elfenbein G, Horowitz MM, Antman KH. Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancer. Bone Marrow Transplant. 2003 Jul;32(2):151-5.
25. Serna DS, Lee SJ, Zhang MJ, Baker kS, Eapen M, Horowitz MM, Klein JP, Rizzo JD, Loberiza FR Jr. Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada. J Clin Oncol. 2003 Oct 15;21(20):3754-60.
26. Bierman PJ, Sweetenham JW, Loberiza FR Jr, Taghipour G, Lazarus HM, Rizzo JD, Schmitz N, van Besien K, Vose JM, Horowitz M, Goldstone A, Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. J Clin Oncol. 2003 Oct 15;21(20):3744-53.
27. van Besien K, Loberiza FR Jr, Bajorunaite R, Armitage JO, Bashey A, Burns LJ, Freytes CO, Gibson J, Horowitz MM, Inwards DJ, Marks DI, Martino R, Maziarz RT, Molina A, Pavlovsky S, Pecora AL, Schouten HC, Shea TC, Lazarus HM, Rizzo JD, Vose JM. Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma. Blood. 2003 Nov 15;102(10):3521-9.
28. Vose JM, Rizzo DJ, Tao-Wu J, Armitage JO, Bashey A, Burns LJ, Christiansen NP, Freytes CO, Gale RP, Gibson J, Giralt SA, Herzig RH, Lemaistre CF, McCarthy PL Jr, Nimer SD, Petersen FB, Schenkein DP, Wiernik PH, Wiley JM, Loberiza FR, Lazarus HM, van Biesen K, Horowitz MM. Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission. Biol Blood Marrow Transplant. 2004 Feb;10(2):116-27.
29. Loberiza FR, Zhang M, Rizzo JD, Lee SJ, Klein JP, Logan BR, Eapen M, Serna DS, Lemaistre CF, Horowitz MM. Patient and transplant center factors associated with 100D mortality after receiving allogeneic hematopoietic stem cell transplantation (HSCT). J Clin Oncol. 2004 Jul 15;22(14_suppl):6026.
30. Cutler CS, Lee SJ, Greenberg P, Deeg HJ, Pérez WS, Anasetti C, Bolwell BJ, Cairo MS, Gale RP, Klein JP, Lazarus HM, Liesveld JL, McCarthy PL, Milone GA, Rizzo JD, Schultz KR, Trigg ME, Keating A, Weisdorf DJ, Antin JH, Horowitz MM. A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. Blood. 2004 Jul 15;104(2):579-85.
31. Freytes CO, Loberiza FR, Rizzo JD, Bashey A, Bredeson CN, Cairo MS, Gale RP, Horowitz MM, Klumpp TR, Martino R, McCarthy PL, Molina A, Pavlovsky S, Pecora AL, Serna DS, Tsai T, Zhang MJ, Vose JM, Lazarus HM, van Besien K, Lymphoma Working Committee of the International Bone Marrow Transplant Registry. Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry. Blood. 2004 Dec 01;104(12):3797-803.
32. Rizzo JD. Evidence-based medicine: can it be applied to stimulation of erythropoiesis for patients with malignancy? Best Pract Res Clin Haematol. 2005;18(3):439-48.
33. Andrykowski MA, Bishop MM, Hahn EA, Cella DF, Beaumont JL, Brady MJ, Horowitz MM, Sobocinski KA, Rizzo JD, Wingard JR. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol. 2005 Jan 20;23(3):599-608.
34. Loberiza FR Jr, Zhang MJ, Lee SJ, Klein JP, LeMaistre CF, Serna DS, Eapen M, Bredeson CN, Horowitz MM, Rizzo JD. Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States. Blood. 2005 Apr 01;105(7):2979-87.
35. Curtis RE, Metayer C, Rizzo JD, Socié G, Sobocinski KA, Flowers ME, Travis WD, Travis LB, Horowitz MM, Deeg HJ. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood. 2005 May 15;105(10):3802-11. PMCID: PMC1895092
36. Nanda A, Rizzo JD, Vogelsang GB. A case of retroperitoneal fibrosis in a patient following HSCT. Bone Marrow Transplant. 2005 Jun;35(11):1125-6.
37. Santo Tomas LH, Loberiza FR Jr, Klein JP, Layde PM, Lipchik RJ, Rizzo JD, Bredeson CN, Horowitz MM. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest. 2005 Jul;128(1):153-61.
38. Jones R, Nieto Y, Rizzo JD, Wall D, Wingard JR, McCarthy P Jr, Hahn T, Steering Committee for Evidence-Based Reviews of the American Society for Blood and Marrow Transplantation. The evolution of the evidence-based review: evaluating the science enhances the art of medicine--statement of the Steering Committee for Evidence-Based Reviews of the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2005 Nov;11(11):819-22.
39. Schwake CJ, Eapen M, Lee SJ, Freytes CO, Giralt SA, Navarro WH, Rizzo JD, van Besien K, Loberiza FR Jr. Differences in characteristics of US hematopoietic stem cell transplantation centers by proportion of racial or ethnic minorities. Biol Blood Marrow Transplant. 2005 Dec;11(12):988-98.
40. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G, Mittleman B, Rizzo JD, Robinson M, Schubert M, Schultz K, Shulman H, Turner M, Vogelsang G, Flowers ME. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005 Dec;11(12):945-56.
41. Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ, Davies SM, Ferrara JL, Socié G. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2006 Feb;12(2):138-51.
42. Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ, Davies SM, Ferrara JL, Socié G. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT). Bone Marrow Transplant. 2006 Feb;37(3):249-61.
43. Navarro WH, Loberiza FR Jr, Bajorunaite R, van Besien K, Vose JM, Lazarus HM, Rizzo JD. Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2006 May;12(5):541-51.
44. Martin PJ, Weisdorf D, Przepiorka D, Hirschfeld S, Farrell A, Rizzo JD, Foley R, Socie G, Carter S, Couriel D, Schultz KR, Flowers ME, Filipovich AH, Saliba R, Vogelsang GB, Pavletic SZ, Lee SJ, Design of Clinical Trials Working Group. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report. Biol Blood Marrow Transplant. 2006 May;12(5):491-505.
45. Schmitz N, Eapen M, Horowitz MM, Zhang MJ, Klein JP, Rizzo JD, Loberiza FR, Gratwohl A, Champlin RE, International Bone Marrow Transplant Registry, European Group for Blood and Marrow Transplantation. Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Blood. 2006 Dec 15;108(13):4288-90. PMCID: PMC1895450
46. Tomblyn MR, Rizzo JD. Are there circumstances in which phase 2 study results should be practice-changing? Hematology Am Soc Hematol Educ Program. 2007:489-92.
47. Oliansky DM, Rizzo JD, Aplan PD, Arceci RJ, Leone L, Ravindranath Y, Sanders JE, Smith FO 3rd, Wilmot F, McCarthy PL Jr, Hahn T. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review. Biol Blood Marrow Transplant. 2007 Jan;13(1):1-25.
48. Bishop MM, Beaumont JL, Hahn EA, Cella D, Andrykowski MA, Brady MJ, Horowitz MM, Sobocinski KA, Rizzo JD, Wingard JR. Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls. J Clin Oncol. 2007 Apr 10;25(11):1403-11.
49. Lazarus HM, Stiff PJ, Carreras J, Logan BR, Akard L, Bolwell BJ, Childs RW, Gale RP, Klein JP, Lill MC, Pérez WS, Stadtmauer EA, Rizzo JD. Utility of single versus tandem autotransplants for advanced testes/germ cell cancer: a center for international blood and marrow transplant research (CIBMTR) analysis. Biol Blood Marrow Transplant. 2007 Jul;13(7):778-89.
50. Giralt S, Logan B, Rizzo D, Zhang MJ, Ballen K, Emmanouilides C, Nath R, Parker P, Porter D, Sandmaier B, Waller EK, Barker J, Pavletic S, Weisdorf D. Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program. Biol Blood Marrow Transplant. 2007 Jul;13(7):844-52.
51. Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B, Goode MJ, Jakubowski AA, Rarick MU, Regan DH, Lichtin AE, American Society of Clinical Oncology, American Society of Hematology. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. J Clin Oncol. 2008 Jan 01;26(1):132-49.
52. Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B, Goode MJ, Jakubowski AA, Rarick MU, Regan DH, Lichtin AE. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update. Blood. 2008 Jan 01;111(1):25-41.
53. Ueno NT, Rizzo JD, Demirer T, Cheng YC, Hegenbart U, Zhang MJ, Bregni M, Carella A, Blaise D, Bashey A, Bitran JD, Bolwell BJ, Elfenbein GJ, Fields KK, Freytes CO, Gale RP, Lazarus HM, Champlin RE, Stiff PJ, Niederwieser D. Allogeneic hematopoietic cell transplantation for metastatic breast cancer. Bone Marrow Transplant. 2008 Mar;41(6):537-45.
54. Bredeson CN, Zhang MJ, Agovi MA, Bacigalupo A, Bahlis NJ, Ballen K, Brown C, Chaudhry MA, Horowitz MM, Kurian S, Quinlan D, Muehlenbien CE, Russell JA, Savoie L, Rizzo JD, Stewart DA. Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide. Biol Blood Marrow Transplant. 2008 Sep;14(9):993-1003. PMCID: PMC3321981
55. Lazarus HM, Carreras J, Boudreau C, Loberiza FR Jr, Armitage JO, Bolwell BJ, Freytes CO, Gale RP, Gibson J, Hale GA, Inwards DJ, LeMaistre CF, Maharaj D, Marks DI, Miller AM, Pavlovsky S, Schouten HC, van Besien K, Vose JM, Bitran JD, Khouri IF, McCarthy PL, Yu H, Rowlings P, Serna DS, Horowitz MM, Rizzo JD, Center For International Blood & Marrow Transplant Research (CIBMTR). Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR). Biol Blood Marrow Transplant. 2008 Dec;14(12):1323-33. PMCID: PMC2638759
56. Rizzo JD, Curtis RE, Socié G, Sobocinski KA, Gilbert E, Landgren O, Travis LB, Travis WD, Flowers ME, Friedman DL, Horowitz MM, Wingard JR, Deeg HJ. Solid cancers after allogeneic hematopoietic cell transplantation. Blood. 2009 Jan 29;113(5):1175-83. PMCID: PMC2635083
57. Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, Sandmaier B. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant. 2009 Mar;15(3):367-9. PMCID: PMC3110087
58. Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD, Leitman SF, Anderlini P, Haagenson MD, Kurian S, Klein JP, Horowitz MM, Confer DL. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood. 2009 Apr 09;113(15):3604-11. PMCID: PMC2668845
59. Landgren O, Gilbert ES, Rizzo JD, Socié G, Banks PM, Sobocinski KA, Horowitz MM, Jaffe ES, Kingma DW, Travis LB, Flowers ME, Martin PJ, Deeg HJ, Curtis RE. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood. 2009 May 14;113(20):4992-5001. PMCID: PMC2686146
60. Jones RB, Nieto Y, Wall D, Wingard JR, Rizzo JD, McCarthy PL Jr, Oliansky D, Hahn T, ASBMT Steering Committee on Evidence-Based Reviews. Methodology for updating published evidence-based reviews evaluating the role of blood and marrow transplantation in the treatment of selected diseases: a policy statement by the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2009 Jun;15(6):761-2.
61. Loberiza FR Jr, Lee SJ, Freytes CO, Giralt SA, Van Besien K, Kurian S, del Cerro P, Toro JJ, Williams LA, Ketelsen SW, Navarro WH, Rizzo JD. Methodological and logistical considerations to study design and data collection in racial/ethnic minority populations evaluating outcome disparity in hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2009 Aug;15(8):903-9. PMCID: PMC2911964
62. Marks DI, Ballen K, Logan BR, Wang Z, Sobocinski KA, Bacigalupo A, Burns LJ, Gupta V, Ho V, McCarthy PL, Ringdén O, Schouten HC, Seftel M, Rizzo JD. The effect of smoking on allogeneic transplant outcomes. Biol Blood Marrow Transplant. 2009 Oct;15(10):1277-87. PMCID: PMC2768519
63. Majhail NS, Bajorunaite R, Lazarus HM, Wang Z, Klein JP, Zhang MJ, Rizzo JD. Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma. Br J Haematol. 2009 Oct;147(1):129-39. PMCID: PMC2748179
64. Fenske TS, Hari PN, Carreras J, Zhang MJ, Kamble RT, Bolwell BJ, Cairo MS, Champlin RE, Chen YB, Freytes CO, Gale RP, Hale GA, Ilhan O, Khoury HJ, Lister J, Maharaj D, Marks DI, Munker R, Pecora AL, Rowlings PA, Shea TC, Stiff P, Wiernik PH, Winter JN, Rizzo JD, van Besien K, Lazarus HM, Vose JM. Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma. Biol Blood Marrow Transplant. 2009 Nov;15(11):1455-64. PMCID: PMC2913553
65. Griffith LM, Cowan MJ, Notarangelo LD, Puck JM, Buckley RH, Candotti F, Conley ME, Fleisher TA, Gaspar HB, Kohn DB, Ochs HD, O'Reilly RJ, Rizzo JD, Roifman CM, Small TN, Shearer WT, Workshop Participants. Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management. J Allergy Clin Immunol. 2009 Dec;124(6):1152-60.e12. PMCID: PMC2831471
66. Baker KS, Davies SM, Majhail NS, Hassebroek A, Klein JP, Ballen KK, Bigelow CL, Frangoul HA, Hardy CL, Bredeson C, Dehn J, Friedman D, Hahn T, Hale G, Lazarus HM, LeMaistre CF, Loberiza F, Maharaj D, McCarthy P, Setterholm M, Spellman S, Trigg M, Maziarz RT, Switzer G, Lee SJ, Rizzo JD. Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2009 Dec;15(12):1543-54. PMCID: PMC2775819
67. Gajewski JL, LeMaistre CF, Silver SM, Lill MC, Selby GB, Horowitz MM, Rizzo JD, Heslop HE, Anasetti C, Maziarz RT. Impending challenges in the hematopoietic stem cell transplantation physician workforce. Biol Blood Marrow Transplant. 2009 Dec;15(12):1493-501.
68. Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, Apperley J, Slavin S, Pasquini M, Sandmaier BM, Barrett J, Blaise D, Lowski R, Horowitz M. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009 Dec;15(12):1628-33. PMCID: PMC2861656
69. Lazarus HM, Zhang MJ, Carreras J, Hayes-Lattin BM, Ataergin AS, Bitran JD, Bolwell BJ, Freytes CO, Gale RP, Goldstein SC, Hale GA, Inwards DJ, Klumpp TR, Marks DI, Maziarz RT, McCarthy PL, Pavlovsky S, Rizzo JD, Shea TC, Schouten HC, Slavin S, Winter JN, van Besien K, Vose JM, Hari PN. A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR. Biol Blood Marrow Transplant. 2010 Jan;16(1):35-45. PMCID: PMC2929576
70. Somerfield MR, Rizzo JD. Can a modest exercise program really improve physical functioning and quality of life among recipients of hematopoietic SCT? Bone Marrow Transplant. 2010 Feb;45(2):217-8.
71. Murphy EA, Ferguson SS, Omondi NA, Getzendaner LC, Gajewski JL, Goldstein GA, Wingard JR, Rizzo JD, Majhail NS. The National Marrow Donor Program's symposium on patient advocacy in cellular transplantation therapy: addressing barriers to hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2010 Feb;16(2):147-56.
72. Bishop MM, Lee SJ, Beaumont JL, Andrykowski MA, Rizzo JD, Sobocinski KA, Wingard JR. The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls. Biol Blood Marrow Transplant. 2010 Feb;16(2):207-14. PMCID: PMC2819641
73. Hari PN, Majhail NS, Zhang MJ, Hassebroek A, Siddiqui F, Ballen K, Bashey A, Bird J, Freytes CO, Gibson J, Hale G, Holmberg L, Kamble R, Kyle RA, Lazarus HM, LeMaistre CF, Loberiza F, Maiolino A, McCarthy PL, Milone G, Omondi N, Reece DE, Seftel M, Trigg M, Vesole D, Weiss B, Wiernik P, Lee SJ, Rizzo JD, Mehta P. Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma. Biol Blood Marrow Transplant. 2010 Mar;16(3):395-402. PMCID: PMC2833344
74. Loberiza FR Jr, Lee SJ, Klein JP, Hassebroek A, Dehn JG, Frangoul HA, Hahn T, Hale G, Lazarus HM, LeMaistre CF, Maziarz RT, Rizzo JD, Majhail NS. Outcomes of hematologic malignancies after unrelated donor hematopoietic cell transplantation according to place of residence. Biol Blood Marrow Transplant. 2010 Mar;16(3):368-75. PMCID: PMC2822013
75. Litzow MR, Tarima S, Pérez WS, Bolwell BJ, Cairo MS, Camitta BM, Cutler CS, de Lima M, Dipersio JF, Gale RP, Keating A, Lazarus HM, Luger S, Marks DI, Maziarz RT, McCarthy PL, Pasquini MC, Phillips GL, Rizzo JD, Sierra J, Tallman MS, Weisdorf DJ. Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood. 2010 Mar 04;115(9):1850-7. PMCID: PMC2832815
76. Goldman JM, Majhail NS, Klein JP, Wang Z, Sobocinski KA, Arora M, Horowitz MM, Rizzo JD. Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase. J Clin Oncol. 2010 Apr 10;28(11):1888-95. PMCID: PMC2860369
77. O'Donnell PV, Pedersen TL, Confer DL, Rizzo JD, Pulsipher MA, Stroncek D, Leitman S, Anderlini P, Donor Health and Safety Working Committee from Center for International Blood and Marrow Transplant Research (CIBMTR). Practice patterns for evaluation, consent, and care of related donors and recipients at hematopoietic cell transplantation centers in the United States. Blood. 2010 Jun 17;115(24):5097-101. PMCID: PMC2890146
78. Joshua TV, Rizzo JD, Zhang MJ, Hari PN, Kurian S, Pasquini M, Majhail NS, Lee SJ, Horowitz MM. Access to hematopoietic stem cell transplantation: effect of race and sex. Cancer. 2010 Jul 15;116(14):3469-76. PMCID: PMC3153958
79. Schriber J, Agovi MA, Ho V, Ballen KK, Bacigalupo A, Lazarus HM, Bredeson CN, Gupta V, Maziarz RT, Hale GA, Litzow MR, Logan B, Bornhauser M, Giller RH, Isola L, Marks DI, Rizzo JD, Pasquini MC. Second unrelated donor hematopoietic cell transplantation for primary graft failure. Biol Blood Marrow Transplant. 2010 Aug;16(8):1099-106. PMCID: PMC2897953
80. Majhail NS, Omondi NA, Denzen E, Murphy EA, Rizzo JD. Access to hematopoietic cell transplantation in the United States. Biol Blood Marrow Transplant. 2010 Aug;16(8):1070-5. PMCID: PMC3144674
81. Navarro WH, Agovi MA, Logan BR, Ballen K, Bolwell BJ, Frangoul H, Gupta V, Hahn T, Ho VT, Juckett M, Lazarus HM, Litzow MR, Liesveld JL, Moreb JS, Marks DI, McCarthy PL, Pasquini MC, Rizzo JD. Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults. Biol Blood Marrow Transplant. 2010 Oct;16(10):1442-50. PMCID: PMC2933950
82. Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Somerfield MR, Temin S. American society of clinical oncology/american society of hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Oncol Pract. 2010 Nov;6(6):317-20. PMCID: PMC2988667
83. Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Arcasoy MO, Spivak JL, Bennett CL, Bohlius J, Evanchuk D, Goode MJ, Jakubowski AA, Regan DH, Somerfield MR, American Society of Hematology and the American Society of Clinical Oncology Practice Guideline Update Committee. American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. Blood. 2010 Nov 18;116(20):4045-59.
84. Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Arcasoy MO, Spivak JL, Bennett CL, Bohlius J, Evanchuk D, Goode MJ, Jakubowski AA, Regan DH, Somerfield MR, American Society of Clinical Oncology, American Society of Hematology. American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Clin Oncol. 2010 Nov 20;28(33):4996-5010.
85. Wingard JR, Huang IC, Sobocinski KA, Andrykowski MA, Cella D, Rizzo JD, Brady M, Horowitz MM, Bishop MM. Factors associated with self-reported physical and mental health after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2010 Dec;16(12):1682-92. PMCID: PMC2975785
86. Uberti JP, Agovi MA, Tarima S, Haagenson M, Gandham S, Anasetti C, Baker KS, Bolwell BJ, Bornhauser M, Chan KW, Copelan E, Davies SM, Finke J, Hale GA, Kollman C, McCarthy PL, Ratanatharathorn V, Ringdén O, Weisdorf DJ, Rizzo JD. Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia. Bone Marrow Transplant. 2011 Jan;46(1):34-43. PMCID: PMC3169009
87. Majhail NS, Brazauskas R, Rizzo JD, Sobecks RM, Wang Z, Horowitz MM, Bolwell B, Wingard JR, Socie G. Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning. Blood. 2011 Jan 06;117(1):316-22. PMCID: PMC3037753
88. Turbeville S, Nicely H, Rizzo JD, Pedersen TL, Orchard PJ, Horwitz ME, Horwitz EM, Veys P, Bonfim C, Al-Seraihy A. Clinical outcomes following hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis VI. Mol Genet Metab. 2011 Feb;102(2):111-5. PMCID: PMC3367500
89. Loren AW, Chow E, Jacobsohn DA, Gilleece M, Halter J, Joshi S, Wang Z, Sobocinski KA, Gupta V, Hale GA, Marks DI, Stadtmauer EA, Apperley J, Cahn JY, Schouten HC, Lazarus HM, Savani BN, McCarthy PL, Jakubowski AA, Kamani NR, Hayes-Lattin B, Maziarz RT, Warwick AB, Sorror ML, Bolwell BJ, Socié G, Wingard JR, Rizzo JD, Majhail NS. Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). Biol Blood Marrow Transplant. 2011 Feb;17(2):157-66. PMCID: PMC3017731
90. Horan JT, Logan BR, Agovi-Johnson MA, Lazarus HM, Bacigalupo AA, Ballen KK, Bredeson CN, Carabasi MH, Gupta V, Hale GA, Khoury HJ, Juckett MB, Litzow MR, Martino R, McCarthy PL, Smith FO, Rizzo JD, Pasquini MC. Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? J Clin Oncol. 2011 Mar 01;29(7):805-13. PMCID: PMC3068057
91. Majhail NS, Bajorunaite R, Lazarus HM, Wang Z, Klein JP, Zhang MJ, Rizzo JD. High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR. Bone Marrow Transplant. 2011 Mar;46(3):385-92. PMCID: PMC2978251
92. Barker CC, Agovi MA, Logan B, Lazarus HM, Ballen KK, Gupta V, Hale GA, Frangoul H, Ho V, Rizzo JD, Pasquini MC, Regimen-Related Toxicity Writing Committee, Center for International Blood and Marrow Transplant Research. Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia. Biol Blood Marrow Transplant. 2011 May;17(5):737-44. PMCID: PMC3035737
93. Wingard JR, Majhail NS, Brazauskas R, Wang Z, Sobocinski KA, Jacobsohn D, Sorror ML, Horowitz MM, Bolwell B, Rizzo JD, Socié G. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol. 2011 Jun 01;29(16):2230-9. PMCID: PMC3107742
94. Majhail NS, Murphy EA, Omondi NA, Robinett P, Gajewski JL, LeMaistre CF, Confer D, Rizzo JD. Allogeneic transplant physician and center capacity in the United States. Biol Blood Marrow Transplant. 2011 Jul;17(7):956-61. PMCID: PMC3114271
95. Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Lint MT, Wingard JR, Tichelli A. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Rev Bras Hematol Hemoter. 2012;34(2):109-33. PMCID: PMC3459383
96. Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Van Lint MT, Wingard JR, Tichelli A, Center for International Blood and Marrow Transplant Research (CIBMTR), American Society for Blood and Marrow Transplantation (ASBMT), European Group for Blood and Marrow Transplantation (EBMT), Asia-Pacific Blood and Marrow Transplantation Group (APBMT), Bone Marrow Transplant Society of Australia and New Zealand (BMTSANZ), East Mediterranean Blood and Marrow Transplantation Group (EMBMT), Sociedade Brasileira de Transplante de Medula Ossea (SBTMO). Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Hematol Oncol Stem Cell Ther. 2012;5(1):1-30. PMCID: PMC3393086
97. Socié G, Rizzo JD. Second solid tumors: screening and management guidelines in long-term survivors after allogeneic stem cell transplantation. Semin Hematol. 2012 Jan;49(1):4-9.
98. Jim HS, Syrjala KL, Rizzo D. Supportive care of hematopoietic cell transplant patients. Biol Blood Marrow Transplant. 2012 Jan;18(1 Suppl):S12-6. PMCID: PMC3445407
99. Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Van Lint MT, Wingard JR, Tichelli A, Center for International Blood and Marrow Transplant Research, American Society for Blood and Marrow Transplantation, European Group for Blood and Marrow Transplantation, Asia-Pacific Blood and Marrow Transplantation Group, Bone Marrow Transplant Society of Australia and New Zealand, East Mediterranean Blood and Marrow Transplantation Group, Sociedade Brasileira de Transplante de Medula Ossea. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Bone Marrow Transplant. 2012 Mar;47(3):337-41. PMCID: PMC3393084
100. Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Van Lint MT, Wingard JR, Tichelli A, Center for International Blood and Marrow Transplant Research (CIBMTR), American Society for Blood and Marrow Transplantation (ASBMT), European Group for Blood and Marrow Transplantation (EBMT), Asia-Pacific Blood and Marrow Transplantation Group (APBMT), Bone Marrow Transplant Society of Australia and New Zealand (BMTSANZ), East Mediterranean Blood and Marrow Transplantation Group (EMBMT),, Sociedade Brasileira de Transplante de Medula Ossea (SBTMO). Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2012 Mar;18(3):348-71. PMCID: PMC3279570
101. Saber W, Opie S, Rizzo JD, Zhang MJ, Horowitz MM, Schriber J. Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia. Blood. 2012 Apr 26;119(17):3908-16. PMCID: PMC3350357
102. Ballen KK, Klein JP, Pedersen TL, Bhatla D, Duerst R, Kurtzberg J, Lazarus HM, LeMaistre CF, McCarthy P, Mehta P, Palmer J, Setterholm M, Wingard JR, Joffe S, Parsons SK, Switzer GE, Lee SJ, Rizzo JD, Majhail NS. Relationship of race/ethnicity and survival after single umbilical cord blood transplantation for adults and children with leukemia and myelodysplastic syndromes. Biol Blood Marrow Transplant. 2012 Jun;18(6):903-12. PMCID: PMC3874400
103. Majhail NS, Brazauskas R, Hassebroek A, Bredeson CN, Hahn T, Hale GA, Horowitz MM, Lazarus HM, Maziarz RT, Wood WA, Parsons SK, Joffe S, Rizzo JD, Lee SJ, Hayes-Lattin BM. Outcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared with children and older adults with acute myeloid leukemia. Biol Blood Marrow Transplant. 2012 Jun;18(6):861-73. PMCID: PMC3288160
104. Martin PJ, Rizzo JD, Wingard JR, Ballen K, Curtin PT, Cutler C, Litzow MR, Nieto Y, Savani BN, Schriber JR, Shaughnessy PJ, Wall DA, Carpenter PA. First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2012 Aug;18(8):1150-63. PMCID: PMC3404151
105. Weisdorf D, Zhang MJ, Arora M, Horowitz MM, Rizzo JD, Eapen M. Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning. Biol Blood Marrow Transplant. 2012 Nov;18(11):1727-33. PMCID: PMC3472079
106. Martinez C, Rizzo JD, Reeves D. Comprehensive stem cell transplant (SCT) outcome data submission. J Clin Oncol. 2012 Dec;30(34_suppl):293.
107. Omondi NA, Ferguson SE, Majhail NS, Denzen EM, Buchanan GR, Haight AE, Labotka RJ, Rizzo JD, Murphy EA. Barriers to hematopoietic cell transplantation clinical trial participation of african american and black youth with sickle cell disease and their parents. J Pediatr Hematol Oncol. 2013 May;35(4):289-98. PMCID: PMC3659415
108. Akpek G, Pasquini MC, Logan B, Agovi MA, Lazarus HM, Marks DI, Bornhaeüser M, Ringdén O, Maziarz RT, Gupta V, Popat U, Maharaj D, Bolwell BJ, Rizzo JD, Ballen KK, Cooke KR, McCarthy PL, Ho VT. Effects of spleen status on early outcomes after hematopoietic cell transplantation. Bone Marrow Transplant. 2013 Jun;48(6):825-31. PMCID: PMC3606905
109. Majhail NS, Rizzo JD, Hahn T, Lee SJ, McCarthy PL, Ammi M, Denzen E, Drexler R, Flesch S, James H, Omondi N, Pedersen TL, Murphy E, Pederson K. Pilot study of patient and caregiver out-of-pocket costs of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2013 Jun;48(6):865-71. PMCID: PMC3596484
110. Hahn T, McCarthy PL Jr, Hassebroek A, Bredeson C, Gajewski JL, Hale GA, Isola LM, Lazarus HM, Lee SJ, Lemaistre CF, Loberiza F, Maziarz RT, Rizzo JD, Joffe S, Parsons S, Majhail NS. Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors. J Clin Oncol. 2013 Jul 01;31(19):2437-49. PMCID: PMC3691359
111. McCarthy PL Jr, Hahn T, Hassebroek A, Bredeson C, Gajewski J, Hale G, Isola L, Lazarus HM, Lee SJ, Lemaistre CF, Loberiza F, Maziarz RT, Rizzo JD, Joffe S, Parsons S, Majhail NS. Trends in use of and survival after autologous hematopoietic cell transplantation in North America, 1995-2005: significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age. Biol Blood Marrow Transplant. 2013 Jul;19(7):1116-23. PMCID: PMC3694566
112. Cornell RF, Hari P, Zhang MJ, Zhong X, Thompson J, Fenske TS, Horowitz MM, Komorowski R, Palmer J, Pasquini MC, Rizzo JD, Saber W, Thomas M, Drobyski WR. Divergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant. 2013 Sep;19(9):1368-73.
113. Majhail NS, Rizzo JD. Surviving the cure: long term followup of hematopoietic cell transplant recipients. Bone Marrow Transplant. 2013 Sep;48(9):1145-51.
114. Saber W, Cutler CS, Nakamura R, Zhang MJ, Atallah E, Rizzo JD, Maziarz RT, Cortes J, Kalaycio ME, Horowitz MM. Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS). Blood. 2013 Sep 12;122(11):1974-82. PMCID: PMC3772501
115. Bredeson C, LeRademacher J, Kato K, Dipersio JF, Agura E, Devine SM, Appelbaum FR, Tomblyn MR, Laport GG, Zhu X, McCarthy PL, Ho VT, Cooke KR, Armstrong E, Smith A, Rizzo JD, Burkart JM, Pasquini MC. Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation. Blood. 2013 Dec 05;122(24):3871-8. PMCID: PMC3854109
116. Pollack J, Schaper K, Renner R, Martinez C, Sorenson S, et al. Extending the Bridg Model with Hematopoietic Cell Transplant Concepts. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation. 2014;20(2 Supplement): S207-208.
117. Joshi S, Savani BN, Chow EJ, Gilleece MH, Halter J, Jacobsohn DA, Pidala J, Quinn GP, Cahn JY, Jakubowski AA, Kamani NR, Lazarus HM, Rizzo JD, Schouten HC, Socie G, Stratton P, Sorror ML, Warwick AB, Wingard JR, Loren AW, Majhail NS. Clinical guide to fertility preservation in hematopoietic cell transplant recipients. Bone Marrow Transplant. 2014 Apr;49(4):477-84. PMCID: PMC4071767
118. Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Van Lint MT, Wingard JR, Tichelli A, Center for International Blood and Marrow Transplant Research (CIBMTR), American Society for Blood and Marrow Transplantation (ASBMT), European Group for Blood and Marrow Transplantation (EBMT), Asia-Pacific Blood and Marrow Transplantation Group (APBMT), Bone Marrow Transplantation Society of Australia and New Zeland (BMTSANZ), East Mediterrnean Blood and Marrow Transplantation Group (EMBMT), Sociedale Brasileira de Transplante de Medula Ossea (SBTMO). [Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation]. Rinsho Ketsueki. 2014 Jun;55(6):607-32.
119. Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio ME, Maziarz RT, Antin JH, Soiffer RJ, Weisdorf DJ, Rizzo JD, Horowitz MM, Saber W. Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. Blood. 2014 Jun 05;123(23):3664-71. PMCID: PMC4047501
120. Gragert L, Eapen M, Williams E, Freeman J, Spellman S, Baitty R, Hartzman R, Rizzo JD, Horowitz M, Confer D, Maiers M. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. N Engl J Med. 2014 Jul 24;371(4):339-48. PMCID: PMC5965695
121. Aljurf M, Rizzo JD, Mohty M, Hussain F, Madrigal A, Pasquini MC, Passweg J, Chaudhri N, Ghavamzadeh A, Solh HE, Atsuta Y, Szer J, Kodera Y, Niederweiser D, Gratwohl A, Horowitz MM. Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts. Bone Marrow Transplant. 2014 Aug;49(8):1016-21.
122. Jacobsen PB, Le-Rademacher J, Jim H, Syrjala K, Wingard JR, Logan B, Wu J, Majhail NS, Wood W, Rizzo JD, Geller NL, Kitko C, Faber E, Abidi MH, Slater S, Horowitz MM, Lee SJ. Exercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902. Biol Blood Marrow Transplant. 2014 Oct;20(10):1530-6. PMCID: PMC4163109
123. Dhakal B, Strouse C, D'Souza A, Arce-Lara C, Esselman J, Eastwood D, Pasquini M, Saber W, Drobyski W, Rizzo JD, Hari PN, Hamadani M. Plerixafor and abbreviated-course granulocyte colony-stimulating factor for mobilizing hematopoietic progenitor cells in light chain amyloidosis. Biol Blood Marrow Transplant. 2014 Dec;20(12):1926-31.
124. Knight JM, Szabo A, Zhao S, Lyness JM, Sahler OJ, Liesveld JL, Sander T, Rizzo JD, Hillard CJ, Moynihan JA. Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study. Neurobiol Stress. 2015;2:44-50. PMCID: PMC4476410
125. Renner R, Carlis J, Maiers M, Rizzo JD, O'Neil C, et al. Integration of Hematopoietic Cell Transplantation Outcomes Data.Data integration in the life sciences:...International Workshop,DILS...: proceedings. DILS (Conference). 2015, :139-146.
126. Kenzik K, Huang IC, Rizzo JD, Shenkman E, Wingard J. Relationships among symptoms, psychosocial factors, and health-related quality of life in hematopoietic stem cell transplant survivors. Support Care Cancer. 2015 Mar;23(3):797-807. PMCID: PMC4312505
127. Ballen KK, Logan BR, Laughlin MJ, He W, Ambruso DR, Armitage SE, Beddard RL, Bhatla D, Hwang WY, Kiss JE, Koegler G, Kurtzberg J, Nagler A, Oh D, Petz LD, Price TH, Quinones RR, Ratanatharathorn V, Rizzo JD, Sazama K, Scaradavou A, Schuster MW, Sender LS, Shpall EJ, Spellman SR, Sutton M, Weitekamp LA, Wingard JR, Eapen M. Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation. Biol Blood Marrow Transplant. 2015 Apr;21(4):688-95. PMCID: PMC4359657
128. Cornell RF, Zhong X, Arce-Lara C, Atallah E, Blust L, Drobyski WR, Fenske TS, Pasquini MC, Rizzo JD, Saber W, Hari PN. Bortezomib-based induction for transplant ineligible AL amyloidosis and feasibility of later transplantation. Bone Marrow Transplant. 2015 Jul;50(7):914-7.
129. Majhail NS, Mau LW, Chitphakdithai P, Payton T, Eckrich M, Joffe S, Lee SJ, LeMaistre CF, LeRademacher J, Loberiza F, Logan B, Parsons SK, Repaczki-Jones R, Robinett P, Rizzo JD, Murphy E, Denzen EM. National Survey of Hematopoietic Cell Transplantation Center Personnel, Infrastructure, and Models of Care Delivery. Biol Blood Marrow Transplant. 2015 Jul;21(7):1308-14. PMCID: PMC4466059
130. Graff TM, Singavi AK, Schmidt W, Eastwood D, Drobyski WR, Horowitz M, Palmer J, Pasquini M, Rizzo DJ, Saber W, Hari P, Fenske TS. Safety of outpatient autologous hematopoietic cell transplantation for multiple myeloma and lymphoma. Bone Marrow Transplant. 2015 Jul;50(7):947-53. PMCID: PMC4490016
131. Sorror ML, Logan BR, Zhu X, Rizzo JD, Cooke KR, McCarthy PL, Ho VT, Horowitz MM, Pasquini MC. Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study. Biol Blood Marrow Transplant. 2015 Aug;21(8):1479-87. PMCID: PMC4512746
132. Ehrhardt MJ, Brazauskas R, He W, Rizzo JD, Shaw BE. Survival of patients who develop solid tumors following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2016 Jan;51(1):83-8. PMCID: PMC4570237
133. Knight JM, Rizzo JD, Logan BR, Wang T, Arevalo JM, Ma J, Cole SW. Low Socioeconomic Status, Adverse Gene Expression Profiles, and Clinical Outcomes in Hematopoietic Stem Cell Transplant Recipients. Clin Cancer Res. 2016 Jan 01;22(1):69-78. PMCID: PMC4703514
134. Majhail NS, Baker KS, Abetti B, Jahagirdar BN, Kamani N, Rizzo JD, Saber W, Salazar L, Schatz B, Syrjala KL, Wingard JR, Denzen EM. Patient and provider preferences: Treatment summary and survivorship care plans after hematopoietic cell transplant. J Clin Oncol. 2016 Jan 20;34(3_suppl):63.
135. Wood WA, Le-Rademacher J, Syrjala KL, Jim H, Jacobsen PB, Knight JM, Abidi MH, Wingard JR, Majhail NS, Geller NL, Rizzo JD, Fei M, Wu J, Horowitz MM, Lee SJ. Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902). Cancer. 2016 Jan 01;122(1):91-8. PMCID: PMC4707096
136. Shaw BE, Lee SJ, Horowitz MM, Wood WA, Rizzo JD, Flynn KE. Can we agree on patient-reported outcome measures for assessing hematopoietic cell transplantation patients? A study from the CIBMTR and BMT CTN. Bone Marrow Transplant. 2016 Sep;51(9):1173-9.
137. Denzen EM, Thao V, Hahn T, Lee SJ, McCarthy PL, Rizzo JD, Ammi M, Drexler R, Flesch S, James H, Omondi N, Murphy E, Pederson K, Majhail NS. Financial impact of allogeneic hematopoietic cell transplantation on patients and families over 2 years: results from a multicenter pilot study. Bone Marrow Transplant. 2016 Sep;51(9):1233-40. PMCID: PMC5014617
138. Knight JM, Syrjala KL, Majhail NS, Martens M, Le-Rademacher J, Logan BR, Lee SJ, Jacobsen PB, Wood WA, Jim HSL, Wingard JR, Horowitz MM, Abidi MH, Fei M, Rawls L, Rizzo JD. Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial. Biol Blood Marrow Transplant. 2016 12;22(12):2256-2263. PMCID: PMC5116244
139. Raj RV, Hari P, Pasquini M, Epperla N, D'Souza A, Fenske T, Shaw BE, Rizzo JD, Drobyski W, Hamadani M. Impact of haploidentical hematopoietic cell transplantation conditioning intensity on the incidence and severity of post-transplantation viral infections. Bone Marrow Transplant. 2016 12;51(12):1602-1604.
140. Wingard JR, Wood WA, Martens M, Le-Rademacher J, Logan B, Knight JM, Jacobsen PB, Jim H, Majhail NS, Syrjala K, Rizzo JD, Lee SJ. Pretransplantation Exercise and Hematopoietic Cell Transplantation Survival: A Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0902). Biol Blood Marrow Transplant. 2017 01;23(1):161-164. PMCID: PMC5182134
141. Epperla N, Pasquini M, Pierce K, Drobyski WR, Rizzo JD, Horowitz MM, Saber W, Zellner K, Ramirez S, Bartz K, Raj RV, Hari PN, Hamadani M. Salvage haploidentical hematopoietic cell transplantation for graft rejection following a prior haploidentical allograft. Bone Marrow Transplant. 2017 01;52(1):147-150.
142. Kanate AS, Hari PN, Pasquini MC, Visotcky A, Ahn KW, Boyd J, Guru Murthy GS, Rizzo JD, Saber W, Drobyski W, Michaelis L, Atallah E, Carlson KS, D'Souza A, Fenske TS, Cumpston A, Bunner P, Craig M, Horowitz MM, Hamadani M. Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation. Biol Blood Marrow Transplant. 2017 Aug;23(8):1295-1302.
143. Hashmi SK, Bredeson C, Duarte RF, Farnia S, Ferrey S, Fitzhugh C, Flowers MED, Gajewski J, Gastineau D, Greenwald M, Jagasia M, Martin P, Rizzo JD, Schmit-Pokorny K, Majhail NS. National Institutes of Health Blood and Marrow Transplant Late Effects Initiative: The Healthcare Delivery Working Group Report. Biol Blood Marrow Transplant. 2017 May;23(5):717-725. PMCID: PMC5378687
144. Arber DA, Borowitz MJ, Cessna M, Etzell J, Foucar K, Hasserjian RP, Rizzo JD, Theil K, Wang SA, Smith AT, Rumble RB, Thomas NE, Vardiman JW. Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology. Arch Pathol Lab Med. 2017 Oct;141(10):1342-1393.
145. Jerkins JH, Hamadani M, Zook F, Epperla N, Shaw BE, Saber W, Rizzo JD, Pasquini M, Chhabra S, Drobyski WR, Hari PN, Shah NN. Alpha-1-antitrypsin for the treatment of steroid-refractory acute gastrointestinal graft-versus-host disease. Am J Hematol. 2017 Oct;92(10):E610-E611.
146. Thompson J, Yin Z, D'Souza A, Fenske T, Hamadani M, Hari P, Rizzo JD, Pasquini M, Saber W, Shah N, Shaw BE, Shahir K, Banerjee A, Drobyski WR. Etanercept and Corticosteroid Therapy for the Treatment of Late-Onset Idiopathic Pneumonia Syndrome. Biol Blood Marrow Transplant. 2017 Nov;23(11):1955-1960.
147. Shaw, B. E., Brazauskas, R., Millard, H. R., Fonstad, R., Flynn, K. E., Abernethy, A., Vogel, J., Petroske, C., Mattila, D., Drexler, R., Lee, S. J., Horowitz, M. M. and Rizzo, J. D. (2017), Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful. Cancer. doi:10.1002/cncr.30936
148. Shaw BE, Brazauskas R, Millard HR, Fonstad R, Flynn KE, Abernethy A, Vogel J, Petroske C, Mattila D, Drexler R, Lee SJ, Horowitz MM, Rizzo JD. Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful. Cancer. 2017 Dec 01;123(23):4687-4700. PMCID: PMC5693638
149. Drobyski WR, Szabo A, Zhu F, Keever-Taylor C, Hebert KM, Dunn R, Yim S, Johnson B, D'Souza A, Eapen M, Fenske TS, Hari P, Hamadani M, Horowitz MM, Rizzo JD, Saber W, Shah N, Shaw B, Pasquini M. Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft--host disease: low incidence of lower gastrointestinal tract disease. Haematologica. 2018 04;103(4):717-727. PMCID: PMC5865423
150. D'Souza A, Millard H, Knight J, Brazauskas R, Lee SJ, Flynn KE, Rizzo JD, Shaw BE. Prevalence of self-reported sleep dysfunction before allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2018 08;53(8):1079-1082. PMCID: PMC6098949
151. Hashmi SK, Lee SJ, Savani BN, Burns L, Wingard JR, Perales MA, Palmer J, Chow E, Meyer E, Marks D, Mohty M, Inamoto Y, Rodriguez C, Nagler A, Sauter C, Komanduri KV, Pidala J, Hamadani M, Johnston L, Shah N, Shaughnessy P, Hamilton BK, Majhail N, Kharfan-Dabaja MA, Schriber J, DeFilipp Z, Tarlock KG, Fanning S, Curtin P, Rizzo JD, Carpenter PA. ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors. Biol Blood Marrow Transplant. 2018 06;24(6):1119-1124.
152. Raj RV, Hamadani M, Szabo A, Pasquini MC, Shah NN, Drobyski WR, Shaw BE, Saber W, Rizzo JD, Jerkins J, Fenske TS, D'Souza A, Dhakal B, Zhang C, Konings S, Hari PN, Chhabra S. Peripheral Blood Grafts for T Cell-Replete Haploidentical Transplantation Increase the Incidence and Severity of Cytokine Release Syndrome. Biol Blood Marrow Transplant. 2018 08;24(8):1664-1670.
153. Knight JM, Kerswill SA, Hari P, Cole SW, Logan BR, D'Souza A, Shah NN, Horowitz MM, Stolley MR, Sloan EK, Giles KE, Costanzo ES, Hamadani M, Chhabra S, Dhakal B, Rizzo JD. Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation. BMC Cancer. 2018 May 24;18(1):593. PMCID: PMC5968588
154. Bhatt NS, Brazauskas R, Tecca HR, Vogel J, Mattila D, Lee SJ, Horowitz MM, Rizzo JD, Shaw BE. Female Sex is Associated With Poor Health-related Quality of Life in Children at 12 Months Post-Hematopoietic Cell Transplantation. J Pediatr Hematol Oncol. 2019 Apr;41(3):233-237. PMCID: PMC6301126
155. Radivoyevitch T, Dean RM, Shaw BE, Brazauskas R, Tecca HR, Molenaar RJ, Battiwalla M, Savani BN, Flowers MED, Cooke KR, Hamilton BK, Kalaycio M, Maciejewski JP, Ahmed I, Akpek G, Bajel A, Buchbinder D, Cahn JY, D'Souza A, Daly A, DeFilipp Z, Ganguly S, Hamadani M, Hayashi RJ, Hematti P, Inamoto Y, Khera N, Kindwall-Keller T, Landau H, Lazarus H, Majhail NS, Marks DI, Olsson RF, Seo S, Steinberg A, William BM, Wirk B, Yared JA, Aljurf M, Abidi MH, Allewelt H, Beitinjaneh A, Cook R, Cornell RF, Fay JW, Hale G, Chakrabarty JH, Jodele S, Kasow KA, Mahindra A, Malone AK, Popat U, Rizzo JD, Schouten HC, Warwick AB, Wood WA, Sekeres MA, Litzow MR, Gale RP, Hashmi SK. Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma. Leuk Res. 2018 11;74:130-136. PMCID: PMC6219911
156. Denzen EM, Preussler JM, Murphy EA, Baker KS, Burns LJ, Foster J, Idossa L, Moore HK, Payton TJ, Haven D, Jahagirdar B, Kamani N, Rizzo JD, Salazar L, Schatz BA, Syrjala KL, Wingard JR, Majhail NS. Tailoring a Survivorship Care Plan: Patient and Provider Preferences for Recipients of Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2019 03;25(3):562-569. PMCID: PMC6445667
157. Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman OF, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Parameswaran V, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Confer DL, Shaw BE. Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors. Haematologica. 2019 Apr;104(4):844-854. PMCID: PMC6442962
158. Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Ball ED, Bolwell BJ, Bunin NJ, Cheerva A, Delgado DC, Dvorak CC, Gillio AP, Hahn TE, Hale GA, Haight AE, Hayes-Lattin BM, Kasow KA, Linenberger M, Magalhaes-Silverman M, Mori S, Prasad VK, Quigg TC, Sahdev I, Schriber JR, Shenoy S, Tse WT, Yanik GA, Navarro WH, Horowitz MM, Confer DL, Shaw BE, Switzer GE. Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results. Biol Blood Marrow Transplant. 2019 05;25(5):955-964. PMCID: PMC6511296
159. Guru Murthy GS, Hari PN, Szabo A, Pasquini M, Narra R, Khan M, Abedin S, Chhabra S, Dhakal B, D'Souza A, Drobyski WR, Rizzo JD, Runaas L, Shah NN, Shaw B, Saber W, Fenske T, Hamadani M. Outcomes of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Performed in the Inpatient versus Outpatient Setting. Biol Blood Marrow Transplant. 2019 04;25(4):827-833.
160. Pulsipher MA, Logan BR, Chitphakdithai P, Kiefer DM, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Bunin NJ, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Shaw BE, Confer DL. Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study. Biol Blood Marrow Transplant. 2019 04;25(4):699-711. PMCID: PMC6453753
161. Snowden JA, Saccardi R, Orchard K, Ljungman P, Duarte RF, Labopin M, McGrath E, Brook N, de Elvira CR, Gordon D, Poirel HA, Ayuk F, Beguin Y, Bonifazi F, Gratwohl A, Milpied N, Moore J, Passweg J, Rizzo JD, Spellman SR, Sierra J, Solano C, Sanchez-Guijo F, Worel N, Gusi A, Adams G, Balan T, Baldomero H, Macq G, Marry E, Mesnil F, Oldani E, Pearce R, Perry J, Raus N, Schanz U, Tran S, Wilcox L, Basak GW, Chabannon C, Corbacioglu S, Dolstra H, Kuball J, Mohty M, Lankester A, Montoto S, Nagler A, Styczynski J, Yakoub-Agha I, de Latour RP, Kroeger N, Brand R, de Wreede LC, van Zwet E, Putter H. Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE). Bone Marrow Transplant. 2019 Oct 21.
162. Renner R, Carlis J, Maiers M, Rizzo JD, O’Neill C, Horowitz M, Gee K, Confer D. Integration of hematopoietic cell transplantation outcomes data : Data standards are not enough Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 2015;9162:139-146.
163. Majhail NS, Rizzo JD. Screening and Prevention Guidelines for Hematopoietic Cell Transplant Survivors Blood and Marrow Transplantation Long Term Management: Prevention and Complications. 9 September 2013:55-64.
164. Rizzo JD, Curtis RE, Deeg HJ, Travis LB. Response: Solid cancers after allogeneic hematopoietic cell transplantation Blood. 2009;114(1):225-226.
165. Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B, Goode MJ, Jakubowski AA, Miller CB, Rarick MU, Regan DH, Lichtin AE. In reply Journal of Clinical Oncology. 2008;26(18):3098-3100.
 
Editorials, Letters to Editor, Other
1. Rizzo JD, Strom BF, Berlin J: Central vascular catheters and infection rates. N Engl J Med 328:445, 1993
2. Rizzo JD: Review of Handbook of Supportive Care in Cancer, Klastersky, Schimpff and Senn, eds. J Natl Cancer Inst 87:1328, 1995
3. Rizzo JD, Cella D, Seidenfeld J: In reply: Letter to the Editor. J Clin Oncol 21:2224-2225.
4. Rizzo JD: Clinical Bone Marrow and Blood Stem Cell Transplantation. [Book Review.] Bone Marrow Transplant 35:319, 2005.
5. Nanda A, Rizzo JD, Vogelsang GB: A Case of Retroperitoneal Fibrosis in a Patient following HSCT. [Letter] Bone Marrow Transplant 35:1125-1126, 2005.
6. Majhail NS, Rizzo JD. Late complications. In: Handbook of hematopoietic stem-cell transplantation; (Wingard J, Gastineau DA, Leather HL, Snyder E, Szczepiorkowski ZM, eds), AABB, MA, USA. [Chapter] In press 2008
7. Majhail NS, Rizzo JD. Screening and prevention guidelines for hematopoietic cell transplant survivors. In: Hematopoietic Stem-Cell Transplantation: A Handbook for Clinicians, 2nd Edition; (Wingard J, Gastineau DA, Leather HL, Snyder E, Szczepiorkowski ZM, eds), AABB, MD, USA. [Chapter 8] 2015 29
 
Abstracts
1. SundarRaj N, RIZZO JD, Anderson S, Goodman W, Thoft R: Expression of unique cytoskeletal-associated proteins upon activation stromal keratocytes during healing of radial keratotomy wounds. ARVO May, 1988
2. RIZZO JD, Vogelsang V, Krumm S, Mock V, Frink B, Bass E: Outpatient BMT for hematologic malignancies: cost-saving or cost-shifting? Blood 90:417a, 1997
3. RIZZO JD, Stiff P, Elias A: Autologous stem cell transplantation for small cell lung cancer. Proceedings of American Society Clinical Oncology 18:469a, 1999
4. Drobyski WR, Klein JP, Pietryga D, Flomenberg N, Kabler-Babbitt C, Vesole DH, Margolis DA, Keever-Taylor C, Horowitz MM, Juckett M, RIZZO JD, Bauer D, Burns WH, Casper JT: A comparative analysis of transplant outcomes in patients receiving unrelated versus highly HLA-disparate haploidentical family member donor marrow grafts for the treatment of leukemia. Blood 94:564a, 1999
5. Vose J, RIZZO JD, Wu J, van Besien K, Lazarus H: Autotransplantation for non-hodgkin lymphoma in 1st relapse or 2nd complete remission - prognostic factor analysis. Blood 96:481a, 2000
6. RIZZO JD, Curtis R, Deeg H, Socié G, Travis L, Flowers M, Sobocinski K, Horowitz MM: Solid cancers in survivors of allogeneic bone marrow transplantation (BMT). Blood 96:557a, 2000
7. RIZZO JD, Ostrowsky B, Horowitz MM, Jarvis W, Pearson M: Infection control and vaccination practices at U.S. and Canadian blood and marrow transplant centers. Program/Proceedings of the American Society of Clinical Oncology 20:20a, 2001
8. Williams SF, RIZZO JD, Wu J, Antman K, Horowitz MM: Syngeneic stem cell transplantation in metastatic breast cancer. Biol Blood Marrow Transplant 7:98a, 2001
9. Metayer C, Curtis RE, Sobocinski KA, Horowitz MM, Vose JM, Weisdorf D, Bhatia S, Fay JW, Freytes CO, Goldstein SC, Herzig R, Keating A, Miller C, Nevill TJ, Pecora AL, RIZZO JD, Travis LB, Williams SF: Myelodysplastic syndrome (MDS) and leukemia after autotransplantation for lymphoma: a multicenter case-control study. Program/Proceedings of the American Society of Clinical Oncology 20:7a, 2001
10. Lee SJ, Bishop MM, Odom LC, Hahn EA, Sobocinski KA, RIZZO JD, Brady MJ, Andrykowski M, Socie G, Cella D, Horowitz MM, Wingard JR, the Late Effects Working Committee of the IBMTR/ABMTR: Preventive health behaviors of stem cell transplant survivors. Blood 98:403a, 2001
11. Loberiza FR, Jr, RIZZO JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC, Lee SJ: Depressive syndrome and early deaths following stem cell transplantation for hematologic diseases. Blood 98:742a, 2001
12. Schmitz N, Champlin RE, Loberiza FR, Jr, Klein JP, RIZZO JD, Gratwohl A, Horowitz MM, the Histocompatibility and Stem Cell Sources Working Committee of the IBMTR: Long term follow-up of allogeneic blood stem cell and bone marrow transplantation: a collaborative study of EBMT and IBMTR. Blood 98:744a, 2001
13. Serna DS, Zhang MJ, Scott-Baker K, Eapen M, Horowitz MM, Klein JP, Lee SJ, RIZZO JD, Loberiza Jr. FR: Trends in survival rates by race after allogeneic hematopoietic stem cell transplantation for leukemia in the United States and Canada. Blood 100:186a, 2002
14. Navarro WH, Loberiza FR, Bajorunaite R, Lazarus HM, RIZZO JD, van Besien K, Vose JM, Horowitz MM on behalf of the Lymphoma Working Committee of the Autologous Blood and Marrow Transplant Registry (ABMTR). Impact of weight on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation (AHCT). Meeting Proceedings of the American Society of Clinical Oncology 22:832a, 2003.
15. Ueno NT, RIZZO JD, Niederwieser D, Cheng Y, Antman K, Stiff PJ, Demirer T, Horowitz MM for the Solid Tumor Working Committees of the International Bone Marrow Transplant Registry/The European Group for Blood and Marrow Transplantation (IBMTR/EBMT). Review of allogeneic hematopoietic stem cell transplantation (ALLO HSCT) in metastatic breast cancer (MBC). Meeting Proceedings of the American Society of Clinical Oncology 22:832a, 2003
16. Bishop M.M., Hahn E., Cella D., Brady M.J., Andrykowski M.A., Beaumont J, RIZZO JD, Wingard JR. The Gift of Life Comes with a Price: The Impact of Hematopoietic Stem Cell Transplant on the Long-term Quality of Life of Survivors and their Spouses. Paper presented at the Annual BMT Tandem Meeting of the IBMTR/ABMTR and ASBMT, Orlando, FL. Biol Blood Marrow Transplant 10:S7, 2004
17. Bishop M.M., Hahn E., Cella D., Brady M.J., Andrykowski M.A., Beaumont J., RIZZO JD, Wingard J.R. The Gift of Life Comes with a Price: The Impact of Hematopoietic Stem Cell Transplant on the Long-term Quality of Life of Survivors and their Spouses. Psychooncology 13:S62-63, 2004
18. Champlin RE, Loberiza, Jr. FR, Eapen M, RIZZO JD, Bredeson CN, Wagner JE, Horowitz MM on behalf of the Histocompatibility Alternative Stem Cell Sources Working Committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). Prevalence of microbially contaminated hematopoietic stem cell products. Blood 104:612a, 2004.
19. Andrykowski MA, Bishop MM, Hahn EA, Cella DF, Beaumont JL, Brady MJ, Horowitz, MM, Sobocinski, KA, RIZZO JD, Wingard JR. Long-term health-related quality of life (HRQOL), growth and spiritual well-being after hematopoietic stem cell transplantation (HSCT). Presented at the 2nd Annual Conference of the American Psychosocial Oncology Society (APOS), Phoenix, AZ, January, 2005. Psycho-Oncology 14(Supp 1) S21, 2005.
20. Goldman JM, Sobocinski KA, Zhang MJ, Klein JP, Ketelsen SW, Giralt SA, Horowitz, MM, RIZZO JD, for the Chronic Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research. Long term outcome after allogeneic hematopoietic cell transplantation (HCT) for CML. Biol Blood Marrow Transplant 12:17, 2006.
21. Ueno NT, RIZZO JD, Cheng YC, Childs R, Stiff PJ, Demirer T, Horowitz M.M, Niederwieser D. Allogeneic hematopoietic cell transplantation (allo HCT) for metastatic breast cancer (MBC). Biol Blood Marrow Transplant 12:32, 2006.
22. Graham HJ, Wade JC, RIZZO JD, Hari P, Miels S, Gruling RJ, Sorensen SH. Recognizing indications for photopheresis in acute and chronic graft-versus-host disease patients. Biol Blood Marrow Transplant 12:167, 2006.
23. Hayes-Lattin B, Carreras J, Zhang M-J, van Besien K, Vose JM, Lazarus HM, RIZZO JD, Hari P. Superior survival after autologous vs. allogeneic hematopoietic stem cell transplantation (HCT) for diffuse large B-cell lymphoma (DLBCL) not explained by differences in chemosensitivity. Blood 108:857a, 2006.
24. Joshua TV, RIZZO JD, Zhang M-J, Horowitz MM. Access to hematopoietic stem cell transplantation: effect of race and gender. Biol Blood Marrow Transplant 13:22, 2007.
25. Bishop MM, Beaumont JL, Lee SJ, Andrykowski MA, RIZZO JD, Wingard JR. Preventive health behaviors of long-term hematopoietic cell transplant survivors. Biol Blood Marrow Transplant 13:48, 2007.
26. Fenske TS, Hari P, Carreras J, Zhang M-J, Kamble R, RIZZO JD, van Besien K, Lazarus HM, Vose JM on behalf of the Writing Committee. Pre-transplant Rituximab therapy is associated with improved progression-free and overall survival in patients undergoing autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma (DLBCL). Blood 110:116, 2007.
27. Baker KS, Hassebroek A, Ballen K, Bigelow C, Frangoul H, Hardy C, Lee S, Switzer G, RIZZO JD, Klein JP, Majhail N, Davies S. Impact of ethnicity and socioeconomic status on outcome of unrelated donor (URD) Hematopoietic Cell Transplantation (HcT)Blood 110:315, 2007.
28. Navarro WH, Agovi M-A, Logan B, Bacigalupo A, Ballen K, Bolwell B, Frangoul H, Gupta V, Hahn T, Juckett M, Lazarus HM, Litzow M, Liesveld J, Moreb J, Marks D, McCarthy P, RIZZO JD, on behalf of the CIBMTR writing committee. Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myeloid leukemia (AML) in adults. Blood 112:26, 2008.
29. Schriber JR, Agovi M-A, Ballen KK, Bacigalupo A, Hale GA, Gupta V, Lazarus HM, Litzow MR, Marks DI, Giller RH, Maziarz RT, Bornhauser M, Isola LM, Bredeson C, RIZZO JD. Second unrelated donor (URD) transplant as a rescue strategy for 122 patients with primary non-engraftment: results from the CIBMTR. Blood 112:295, 2008.
30. Majhail NS, Wang Z, Zhang M-J, Lazarus HM, Bajorunaite R, RIZZO JD. Long-term survival and late relapse in 2-year survivors of autologous hematopoietic cell transplantation for lymphoma. Biol Blood Marrow Transplant 15:22-23, 2009.
31. O'Donnell P, Pedersen T, Confer D, Pulsipher M, RIZZO JD, Stroncek D, Leitman S, Anderlini P. Practice patterns for evaluation, consent and care of related donors and recipients at hematopoietic stem cell transplant centers in the United States: is conflict-of-interest an unrecognized issue? Biol Blood Marrow Transplant 15:8-9, 2009.
32. Barker CC, Agovi M-A, Logan B, Gupta V, Lazarus HM, Ballen KK, Hale GA, Frangoul H, RIZZO JD, Pasquini MC. Obesity adversely affects survival of pediatric patients with severe aplastic anemia after hematopoietic cell transplantation. Blood 114:271, 2009.
33. Goldman JM, Majhail NS, Klein JP, Wang Z, Sobocinski KA, Arora M, Horowitz MM, RIZZO JD. Long-term survival and late relapse in 5-year survivors of allogeneic hematopoietic-cell transplantation (HCT) for chronic myeloid leukemia (CML) in first chronic phase. Blood 114:1288, 2009.
34. Horan, J Logan BR, Agovi M-A, Lazarus HM, Bacigalupo A, Ballen K, Martino R, Juckett MB, Khoury HJ, Bredeson C, Gupta V, Smith FO, Hale G, Carabasi M, McCarthy PL, RIZZO JD, Pasquini MC. Reducing the risk for transplant related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? Blood 114:269, 2009.
35. Wingard JR, Majhail NS, Bajorunaite R, Wang Z, Sobocinski KA, Jacobsohn D, Sorror ML, RIZZO JD, Bolwell BJ, Socié G. Long-term survival and late deaths in 2-year survivors of myeloablative allogeneic hematopoietic-cell transplantation for hematologic disorders. Blood 114:215, 2009.
36. Hahn T, McCarthy PL, Hassebroek A, RIZZO JD, Parsons S, Joffe S, Majhail N. Transplant utilization, procedure patterns and patient characteristics in North American transplant centers from 1994-2005. Biol Blood Marrow Transplant 16:S198-S199, 2010.
37. Loren AW, Wang Z, Chow E, Jacobsohn DA, Gilleece M, Halter J, Joshi S, Sorror ML, Bolwell BJ, Wingard J, Socié G, RIZZO JD, Majhail NS. Pregnancy after hematopoietic-cell transplantation: a report from the late effects committee of the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant 16:S176, 2010.
38. Majhail NS, Bajorunaite R, Sobecks RM, Wang Z, Jacobsohn DA, Sorror ML, Bolwell BJ, Wingard JR, RIZZO JD, Socié G. Second solid cancers after allogeneic hematopoietic-cell transplantation using busulfan-cyclophosphamide conditioning. Biol Blood Marrow Transplant 16:S176-S177, 2010.
39. Akpek G, Pasquini MC, Agovi MA, Logan B, Cooke KR, Maziarz RT, Gupta V, Lazarus HM, Hale GA, Marks DI, Maharaj D, Popat U, Carabasi M, Bornhaeuser M, Bolwell BJ, Ringden O, Ballen KK, RIZZO JD, McCarthy PL, Ho VT. Spleen status and engraftment after allogeneic hematopoietic stem cell transplantation. Blood 116:1432-1433, 2011.
40. Ballen KK, Klein JP, Pedersen TL, Kurtzberg J, Lazarus HM, LeMaistre CF, Mehta P, Palmer J, Setterholm M, Wingard JR, Joffe S, Parsons SK, Switzer GE, Lee SJ, RIZZO JD, Majhail NS, and for the Health Policy Working Committee of the CIBMTR. Relationship of race/ethnicity and survival after single umbilical cord blood transplantation. Blood 116:104-105, 2010.
41. Hahn T, McCarthy PL, Hassebroek A, Klein JP, RIZZO JD, Parsons S, Joffe S, Majhail NS. Significant improvement in day 100 and 1-year overall survival in patients who underwent myeloablative allogeneic hematopoietic cell transplant in the US or Canada between 1994 and 2005. Blood 116:1442, 2010.
42. Majhail NS, Quinn G, Brazauskas R, Wang Z, Chow E, Gilleece M, Halter J, Joshi S, Pidala J, Bolwell B, Jacobsohn D, Socie G, Sorror M, Wingard JR, RIZZO JD, Loren A. Transplant physician perceptions and practice patterns regarding fertility preservation in hematopoietic-cell transplant (HCT) recipients. Biol Blood Marrow Transplant 17: S240, 2011.
43. McCarthy PL, Hahn T, Hassebroek A, Klein JP, RIZZO JD, Parsons S, Joffe S, Majhail NS. Significant improvement in overall survival in patients who underwent autologous hematopoietic cell transplant in the US or Canada between 1994 and 2005. Blood 116:990, 2011.
44. Stadtmauer EA, Krishnan A, Pasquini MC, Ewell M, Alyea EP, Antin JH, Castro-Malaspina H, Kassim AA, Negrin R, Qazilbash MH, RIZZO JD, Rowley SD, Sahebi F, Somlo G, Vesole DH, Vogl DT, Weisdorf DJ, Geller N, Horowitz MM, Maloney DG, Giralt S. Tandem autologous stem cell transplants with or without maintenance therapy versus single autologous transplant followed by HLA-matched sibling nonmyeloablative allogeneic stem cell transplant for patients with high risk multiple myeloma: results from the BMT CTN 0102 Trial. Blood 116:233-234, 2011.
45. Picozzi V, J Releford J, Faure M, Eastwood D, RIZZO JD. The value of the hematologist: appropriate use of diagnostic endoscopy in microcytic and normocytic anemias (MNA). Blood 118:342a, 2011.
46. McClune B, Pedersen TL, Ahn KW, Warlick ED, Pidala J, Waller EK, RIZZO JD, Cairo MS, Woolfrey A, Artz A, Lazarus HM, Weisdorf DJ. Reduced intensity or non-ablative hematopoietic cell transplantation in older patients with non-Hodgkin lymphoma (NHL): encouraging survival for patients ≥55 years. Blood 118:1015a, 2011.
47. Weisdorf DJ, Zhang MJ, Arora M, RIZZO JD, Horowitz MM, Eapen M. Graft-versus-host disease (GVHD) induced graft-versus-leukemia (GVL) effect: more impact on later relapse and disease-free survival following reduced intensity conditioning. Blood 118:1014a, 2011
48. Bredeson C, Burkart J, Zhu X, Sun Y, LeRademacher J, Pasquini M, Armstrong E, RIZZO JD, Kato K. Chimerism testing with reduced intensity intravenous Busulfan-based conditioning regimens: once is enough. Biol Blood Marrow Transplant 18:S331-S332, 2012.
49. Bredeson C, Burkart J, Sun Y, Zhu X, LeRademacher J, RIZZO JD, Armstrong E, Pasquini M, Kato K. Dose, schedule and PK practices with IV busulfan-based conditioning regimens in a non-inferiority trial: heterogeneous practices but low VOD and TRM. Biol Blood Marrow Transplant 18:S325, 2012.
50. Pederson KA, RIZZO JD, Hahn T, Lee SJ, McCarthy PL, Ammi MS, Denzen EM, Drexler R, Flesch SM, James H, Omondi NA, Pedersen TL, Murphy EA, Majhail NS. Patient and Family Out-of-Pocket Costs of Allogeneic Hematopoietic Cell Transplantation (HCT): A Pilot Study. Biol Blood Marrow Transplant 18:S237-S238, 2012.
51. Cornell RF, Thompson J, Drobyski WR, Fenske TS, Horowitz MM, Palmer JM, Pasquini MC, Saad AA, RIZZO JD, Saber W, Zhang M-J, Zhong X, Hari P. Risk factors and clinical features of autologous graft-versus-host disease/engraftment syndrome after autologous hematopoietic cell (HCT) transplantation. Biol Blood Marrow Transplant 18:S250, 2012
52. Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio M, Maziarz RT, Antin JH, Soiffer RJ, Weisdorf DJ, RIZZO JD, Horowitz MM, Saber W. Validation and Refinement Of The Disease Risk Index For Stratification Of Patients Undergoing Allogeneic Stem Cell Transplantation: A Study Of 13,131 Patients From The Center For International Blood & Marrow Transplant Research. Blood 122:548, 2013
53. Lee SJ, Le-Rademacher J, Jim H, Syrjala KL, Wingard JR, Logan BR, Wu J, Majhail NS, Wood WA, RIZZO JD, Geller NL, Kitko CL, Faber Jr EA, Abidi MH, Slater SE, Horowitz MM, Jacobsen P. Exercise and Stress Management Training For Patients Undergoing Autologous Or Allogeneic Hematopoietic Cell Transplantation. Results From Blood and Marrow Transplant Clinical Trials Network BMT CTN 0902. Blood122: 699, 2013
54. Majhail NS, Payton T, Mau LW, Le-Rademacher J, Chitphakdithai P, Ekrich M, Joffe S, Lee SJ, LeMaistre CF, Loberiza Jr FR, Logan BR, Murphy EA, Parsons SK, Repaczki-Jones R, RIZZO JD, Robinett P, Denzen E. Provider and Center Characteristics Of US Transplant Centers and Their Association With Survival After Allogeneic Hematopoietic Cell Transplantation (HCT) In Adults: Results From a National Survey Conducted By The Center For International Blood and Marrow Transplant Research (CIBMTR). Blood 122:1687, 2013
55. Pulsipher MA, Chitphakdithai P, Logan BR, Switzer GE, Riches M, Moffitt HL, RIZZO JD, Anderlini P, Leitman SF, Vaarni JW, Hays A, Kobusingye H, Miller jp, Drexler RJ, King R, Horowitz MM, Confer DL, Navarro WH. Related PBSC Donors Age > 60 Have High Rates of Baseline and Donation-Related Pain and Slow Recovery: First Report from the Related Donor Safety Study (RDSafe). BMT Tandem Meetings, Dallas TX, USA, March 2014.
56. Kroll TM, Singavi A, Schmidt W, Eastwood D, Drobyski W, Horowitz MM, Palmer J, Pasquini M, RIZZO JD, Saber W, Parameswaran NH, Fenske T. Safety of Outpatient Autologous Hematopoietic Cell Transplantation (AuHCT) for Multiple Myeloma and Lymphoma. BMT Tandem Meetings, Dallas TX, USA, February 2014.
57. Pollack J, Schaper K, Renner R, Martinez C, Sorensen S, Milius B, O’Neill C, Jones RB, RIZZO JD. Extending the Bridg Model with Hematopoietic Cell Transplant Concepts. BMT Tandem Meetings, Dallas TX, USA, February 2014.
58. Saber W, Cutler C, Nakamura R, Zhang MJ, Atallah E, RIZZO JD, Maziarz RT, Cortes JE, Kalaycio M, Horowitz MM. Comparison of Outcomes After Related and Unrelated Hematopoietic Cell Transplantation in Adults with Myelodysplastic Syndromes: A Report From the Center for International Blood and Marrow Transplant Research (CIBMTR). Blood 120:355a, 2012
59. Pasquini MC, Logan BR, Ho VT, McCarthy, PL Jr., Cooke KR, RIZZO JD, Zhu X, Sorror ML. Comorbidity Index (CI) in Autologous Hematopoietic Cell Transplantation (HCT) for Malignant Diseases: Validation of the HCT-CI. Blood 120:814a, 2012
60. Sorror ML, Logan BR, Zhu X, RIZZO JD, Cooke KR, McCarthy, PL Jr., Ho VT, Storer B, Pasquini MC. Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) for HCT Outcomes At US Transplant Centers: A Center for International Blood and Marrow Transplant Research (CIBMTR) Study. Blood 120:733a, 2012
61. Thakar MS, Logan BR, Pasquini MC, McCarthy PL Jr, Ho VT, Cooke KR, Zhu X, RIZZO JD, Sorror ML. The Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Can Prospectively Discriminate Risks Affecting Overall Survival in Pediatric and Adult Patients with Non-Malignant Diseases. Blood 120:737a, 2012
62. Eckrich MJ, Le-Rademacher J, RIZZO JD, Baker KS, Bhatla D, Buchbinder DK, Cooke KR, Duerst R, Gilman A, Frangoul H, Kapoor N, Kernan NA, Verneris M, Eapen M. The Effect of Transplant Center Characteristics on Survival After Pediatric Hematopoietic Cell Transplantation. Blood 120:762a, 2012
63. Atallah E, Pedersen TL, Warlick ED, Dircks A, Weisdorf D, Horowitz MM, RIZZO JD. The Outcome of Hematopoietic Cell Transplantation (HCT) for Myelodysplastic Syndrome (MDS) in Adults >=65 Years of Age: First Report of the Coverage with Evidence Development (CED) in Medicare Beneficiaries. Blood 120:1983a, 2012
64. Bredeson C, Le-Rademacher J, Zhu X, Burkart J, Kato K, Armstrong E, Sun Y, Smith A, Ho VT, McCarthy PL, Cooke KR, RIZZO JD, Pasquini MC, Improved Survival with Intraveneous Busulfan (IV BU) Compared to Total Body Irradiation (TBI)-Based Myeloablative Conditioning Regimens: A CIBMTR Prospective Study. BMT Tandem Meetings, Salt Lake City, UT, USA, February 2013
65. Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio M, Maziarz RT, Antin JH, Soiffer RJ, Weisdorf DJ, RIZZO JD, Horowitz MM, Saber W. Validation and Refinement Of The Disease Risk Index For Stratification Of Patients Undergoing Allogeneic Stem Cell Transplantation: A Study Of 13,131 Patients From The Center For International Blood & Marrow Transplant Research. Blood 122:548, 2013
66. Knight JM, RIZZO JD, Logan BR, Wang T, Cole SW, Altered Genetic Transcription Profiles among Hematopoietic Stem Cell Transplant Recipients based on Socioeconomic Status. Invited oral paper presentation, American Psychosomatic Society, San Francisco, CA (3/2014)*Selected for press release
67. Knight JM, RIZZO JD, Logan BR, Wang T, Cole SW, Altered Genetic Transcription Profiles among Hematopoietic Stem Cell Transplant Recipients based on Socioeconomic Status. Oral paper presentation, Society of Biological Psychiatry, New York, NY (5/2014)
68. Wood W, Le-Rademacher J, Fei M, Logan BR, Syrjala K, Majhail NS, Wingard JR, Abidi MH, Geller NL, Wu J, RIZZO JD, Faber E, Jim H, Jacobsen PB, Horowitz MM, Lee SJ. Patient-Reported Quality of Life Is an Independent Predictor of Survival after Allogeneic Hematopoietic Cell Transplantation: A Secondary Analysis from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902. Blood 124:206a, 2014.
69. Seftel MD, Neuberg D, Zhang MJ, Wang HL, Bergeron J, Couban S, DeAngelo DJ, de Lima MJ, Devine SM, Eapen M, Horowitz MM, Pasquini MC, RIZZO JD, Saber W, Sallan SE, Sandmaier BM, Weisdorf DJ. Superiority of Pediatric Chemotherapy over 37 Allogeneic Hematopoietic Cell Transplantation for Philadelphia Chromosome Negative Adult ALL in First Complete Remission: A Combined Analysis of Dana-Farber ALL Consortium and CIBMTR Cohorts. Blood 124:319a, 2014.
70. Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Switzer GE, Riches ML, RIZZO JD, Anderlini P, Leitman SF, Varni JW, Hays A, Kobusingye H, Besser RM, Miller JP, Drexler RJ, King RJ, Horowitz MM, Navarro WH, Confer DL. Baseline Symptoms, Female Sex, and Younger Age Are Correlated with Higher Levels of Peri-Collection Pain, Symptoms, and Persistent Discomfort One Year after Related Donor BM and PBSC Donation: An Analysis of the Related Donor Safety Study (RDSafe). Blood 124:3847a, 2014.
71. Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai PR, Switzer GE, Riches ML, RIZZO JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP Drexler RJ, King RJ, Horowitz MM, Confer DL. Related PBSC Donors Experience Higher Levels of Pain and Donation-Related Symptoms and Less Complete Rates of Recovery Compared to Unrelated Donors: Primary Analysis of the Related Donor Safety Study (RDSafe). (Oral) Biol Blood Marrow Transplant, 21:S41 - S42, 2015.
72. Knight J, Cole S, Logan BR, Wang T, RIZZO JD Clinical Outcomes Among Unrelated Donor Transplant Recipients for Acute Myelogenous Leukemia As a Function of Socioeconomic Status and Related Transcriptome Differences. (Oral) Biol Blood Marrow Transplant, 21:S76 - S77, 2015.
73. Denzen EM, Murphy EA, Baker KS, Abetti B, Jahagirdar B, Kamani NR, RIZZO JD, Saber W, Salazar L, Schatz BA, Syrjala KL, Wingard JR, Majhail NS. Patient and Provider Preferences for Survivorship Care Plans for Allogeneic Hematopoietic Cell Transplantation (HCT) Survivors: A Qualitative Study. (Oral) Biol Blood Marrow Transplant, 21:S174 - S175, 2015.
74. Dhakal B, Martens M, Kapke J, D'Souza A, Pasquini MC, Saber W, Hamadani M, Drobyski W, RIZZO JD, Horowitz MM, Zhang MJ, Hari PN. Outcomes of Allogeneic Hematopoietic Cell Transplantation (AHCT) for Multiple Myeloma (MM): Impact of Disease Risk and Conditioning Regimen. (Oral) Biol Blood Marrow Transplant, 21: S278 - S279, 2015.
75. Ehrhardt MJ, Brazauskas R, He W, RIZZO JD, Shaw BE, Survival of patients who develop solid tumors following hematopoietic stem cell transplantation. Paper Presentation, 14th International Conference on Long-Term Complications of Treatment of Children and Adolescents for Cancer, Arlington VA, June, 2015.
76. Knight JM, Martens M, Syrjala KL Le-Rademacher J, Logan BR, Lee SJ, Jacobsen PB, Wood WA, Jim H, Wingard JR, Horowitz MM, Majhail NS, Abidi MH, Geller NL, Fei M, Wu J, RIZZO JD. Pre-transplant health-related quality of life factors as predictors of outcomes following hematopoietic cell transplantation: A study from the BMT CTN 0902 trial. Oral Presentation, 2015 World Congress of Psycho-Oncology, Washington, DC, USA, July 28 – August 1, 2015.
77. Syrjala KL, Sutton SK, Yi JC, Jim HSL, Knight JM, Wood WA, Jacobsen PB, Majhail NS, Abidi MH, Wingard JR, Horowitz MM, Rizzo JD, Le-Rademacher J, Wu J, Lee SJ. Cancer and Treatment Distress Measurement over Time in a Multicenter Cohort of Hematopoietic Cell Transplantation (HCT) Recipients (BMT CTN 0902). Psycho-Oncology, 2015, 24 Suppl 2:84-85.
78. Knight J, Martens M, Syrjala K, Le-Rademacher J, Logan BR, Lee S, Jacobsen P, Wood W, Jim H, Wingard J, Horowitz M, Majhail N, Abidi M, Geller N, Fei M, Wu J, Rizzo JD. Pre-transplant health-related quality of life factors as predictors of outcomes following hematopoietic cell transplantation: A study from the BMT CTN 0902 trial. Psycho-Oncology, 2015, 24 Suppl 2:99.
79. D'Souza A, Millard HR, Knight JM, Brazauskas R, Vogel J, Mattila D, Flynn K, Lee SL, Horowitz MM, Rizzo JD, Shaw BE. Patient-Reported Sleep Quality at Baseline Correlates with 1-Year Survival after Allogeneic Hematopoietic Cell Transplantation in Adults. Blood 2017 130:3447.
80. Chhabra S, Hari P, Visotcky A, Shah NN, Rizzo JD, Saber W, D'Souza A, Dhakal B, Anshu A, Thompson R, Fenske TS, Shaw BE, Drobyski WR, Pasquini MC, Hamadani M. Ixazomib for Chronic Graft-Versus-Host Disease (cGVHD) Prophylaxis in Patients Undergoing Allogeneic Transplantation (alloHCT): Preliminary Results of a Phase I/II Study. Blood 2017 130:1974
81. Knight JM, Costanzo ES, Singh S, Yin Z, Szabo A, Hillard CJ, Rizzo JD, Raison CL, D’Souza A, Coe CL, Drobyski WR. Inflammation and the brain: tocilizumab may redefine our understanding of depression and related symptoms in the medically ill. Oral Paper Presentation, Academy of Consultation Liaison Psychiatry, Orlando, FL (11/2018)
82. Knight J.M., Rizzo JD. Hari P., D’Souza A., Logan B.R., Giles K.E., Hamadani M., Chhabra S., Dhakal B., Shah N., & Cole S.W. (2018) Translational psycho-oncology: Neurally regulating cancer through propranolol by inhibiting stress-related gene expression profiles associated with adverse cancer outcomes. Academy of Consultation Liaison Psychiatry. Orlando, FL. November 16, 2018.
 
Non-Peer Reviewed Educational Products
1. Jim HSL, Syrjala KL, RIZZO JD. Supportive care of hematopoietic cell transplant patients. Biol Blood Marrow Transplant 18:S12-S16, 2012.
 

jenkins-FCD Prod-410 e9586552fe7f53c71f7923aa6e27aeabbd3c2473